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Abstract
The Panel on Food Additives and Flavourings (FAF) provided a scientific opinion re-evaluating the
safety of dimethyl polysiloxane (E 900) as a food additive. E 900 was evaluated by the Scientific
Committee on Food (SCF) in 1990 and agreed with the Acceptable Daily Intake (ADI) of 1.5 mg/kg
body weight (bw) per day previously established by Joint FAO/WHO Expert Committee on Food
Additives (JECFA) in 1974. Dimethyl polysiloxane was only absorbed to a very limited extent from the
gastrointestinal tract following oral administration and the vast majority was excreted unchanged in
the faeces. Corneal opacities and other effects on cornea were observed in studies in rats. These
effects are considered to be caused by direct contact with the test substance in the feed and/or with
the test substance in the faeces and not due to systemic exposure. The Panel considered that oral
exposure of dimethyl polysiloxane did not result in any systemic adverse effects in any species and
dose tested and there is no concern with respect to genotoxicity of dimethyl polysiloxane (E 900).
From a 26-month toxicity study in rats, a No Observed Adverse Effect Level (NOAEL) of 1,742 and
2,055 mg dimethyl polysiloxane/kg bw per day for female and male, respectively, was identified. Using
the NOAEL 1,742 mg/kg bw per day, the Panel established an ADI of 17 mg/kg bw per day for E 900
by applying an uncertainty factor of 100. Accordingly, the ADI for dimethyl polysiloxane (E 900) of
1.5 mg/kg bw per day, established by SCF in 1990, is withdrawn. The exposure estimates for the
different population groups of all exposure scenarios did not exceed the ADI of 17 mg/kg bw per day
for E 900. The Panel concluded that there is not a safety concern at the reported uses and use levels
for dimethyl polysiloxane (E 900). The Panel also proposed a number of recommendations for the EU
specifications to be amended.
© 2020 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf
of European Food Safety Authority.
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Summary
Following a request from the European Commission, the Panel on Food Additives and Flavourings
(FAF) was asked to deliver a scientific opinion on the re-evaluation of dimethyl polysiloxane (E 900) as
a food additive. Dimethyl polysiloxane (E 900) is authorised food additives in the European Union (EU)
according to Annex II and Annex III of Regulation (EC) No 1333/2008 on food additives and
specifications have been defined in the Commission Regulation (EU) No 231/2012.
In 1990, the Scientific Committee on Food (SCF) evaluated dimethyl polysiloxane and agreed with
the acceptable daily intake (ADI) of 1.5 mg/kg body weight (bw) per day established previously by
Joint FAO/WHO Expert Committee on Food Additives (JECFA) in 1974 based on a No Observed
Adverse Effect Level (NOAEL) of 150 mg/kg bw per day from a long-term toxicity rat study performed
in 1959. JECFA in its latest evaluation in 2011 considered new studies and concluded that the ocular
lesions were caused by local toxicity when the eyes of laboratory animals were exposed to dimethyl
polysiloxane through contact with the substance in feed or faeces or through grooming of
contaminated fur. The Committee re-established an ADI of 0–1.5 mg/kg bw per day and withdrew the
temporary ADI of 0–0.8 mg/kg bw established in 2008.
Having evaluated information submitted by interested parties on dimethyl polysiloxane and its
manufacturing process, the Panel would recommend that specifications should be updated in order to
better describe the material used as a food additive and ensure its safety of use:
• Include the range of the weight average molecular weight (Mw) and number average molecular
weight (Mn) for dimethyl polysiloxane used as a food additive E 900.
• Include a maximum limit for cyclopolysiloxanes.
• Include a maximum limit for copper since copper-based catalysts are used in the manufacturing
process.
• Setting lower limits for toxic elements (arsenic, lead, mercury).
• Revising the name of the substance to ‘poly(dimethylsiloxane)’.
Dimethyl polysiloxane (various compositions and different viscosities – 10, 350 and 1,000
centistokes) was only absorbed to a very limited extent from the gastrointestinal tract following oral
administration to mice, rats, monkeys and humans. The vast majority (more than 99.9%) of the orally
administered dimethyl polysiloxane was excreted unchanged in the faeces.
The acute toxicity of dimethyl polysiloxane is low. There is no concern with respect to genotoxicity
of dimethyl polysiloxane (E 900).
Corneal opacities and other effects on cornea observed in rats studies have been considered as
caused by direct contact with the test substance in the feed, or with the test substance in the faeces
and not due to systemic exposure.
The Panel considered that oral exposure of dimethyl polysiloxane did not result in any systemic
adverse effects in any species and dose tested. From a 26-month toxicity study in rats (Kawabe et al.,
2005) an NOAEL of 1,894 and 2,234 mg/kg bw per day for females and males, respectively, was
identified. Considering that the test material contained 92% of dimethyl polysiloxane, these NOAELs
correspond to 1,742 and 2,055 mg dimethyl polysiloxane/kg bw per day. The Panel noted that the test
item was reported not to be used as a food additive in the EU. Nevertheless, the Panel considered it
relevant for the risk assessment of the food additive E 900 because the viscosity complied with the
one indicated in the EU specifications.
The Panel considered that the NOAEL of 1,742 mg/kg bw per day, the highest dose tested, could
be used to derive an ADI for dimethyl polysiloxane (E 900). Using an uncertainty factor of 100, the
Panel derived an ADI of 17 mg/kg bw per day for dimethyl polysiloxane (E 900). Accordingly, the ADI
for dimethyl polysiloxane (E 900) of 1.5 mg/kg bw per day, established by SCF in 1990, is withdrawn.
Dietary exposure to dimethyl polysiloxane (E 900) from its use as a food additive according to Annex
II of Regulation 1333/2008 was calculated according to different exposure scenarios based on maximum
permitted level (MPLs) and reported use levels, as described in Section 3.4. Two food categories that
may contain dimethyl polysiloxane (E 900) according to Annex III of Regulation 1333/2008 were also
considered in these exposure scenarios.
The exposure estimates in the regulatory maximum level exposure assessment scenario reached at
the mean 0.23 mg/kg bw per day and 0.51 mg/kg bw per day at the 95th percentile, both for toddlers
(Table 4).
Considering that dimethyl polysiloxane (E 900) is authorised in flavoured drinks and changes the
organoleptic properties of these drinks, the Panel selected the brand-loyal scenario as the most
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relevant scenario for risk characterisation. In this scenario, mean exposure to dimethyl polysiloxane
(E 900) from its use as a food additive ranged from 0.01 mg/kg bw per day in adults and the elderly
to 0.16 mg/kg bw per day in children. The 95th percentile of exposure to dimethyl polysiloxane
(E 900) ranged from 0.02 mg/kg bw per day in the elderly to 0.49 mg/kg bw per day in toddlers.
The Panel considered also the exposure estimates in the refined scenarios as overestimates of the
exposure to dimethyl polysiloxane (E 900) from its use as a food additive according to Annex II of
Regulation 1333/2008. This was mainly due to the inclusion of 75% of the food products labelled with
dimethyl polysiloxane (E 900) in the Mintel GNPD in the refined scenarios, and the assumption that all
foods belonging to the food categories included in these scenarios contained dimethyl polysiloxane
(E 900) at the reported use levels.
The exposure estimates for the different population groups of all exposure scenarios did not exceed
the ADI of 17 mg/kg bw per day for dimethyl polysiloxane (E 900). The Panel concluded that there is
no safety concern at the reported uses and use levels for dimethyl polysiloxane (E 900).
The Panel also proposed a number of recommendations for the EU specifications to be amended.
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1. Introduction
The present opinion document deals with the re-evaluation of dimethyl polysiloxane (E 900) as a
food additive.
1.1. Background and Terms of Reference as provided by the European
Commission
1.1.1. Background
Regulation (EC) No 1333/20081 of the European Parliament and of the Council on food additives
requires that food additives are subject to a safety evaluation by the European Food Safety Authority
(EFSA) before they are permitted for use in the European Union. In addition, it is foreseen that food
additives must be kept under continuous observation and must be re-evaluated by EFSA.
For this purpose, a programme for the re-evaluation of food additives that were already permitted in
the European Union before 20 January 2009 has been set up under the Regulation (EU) No 257/2010.2
This Regulation also foresees that food additives are re-evaluated whenever necessary in light of
changing conditions of use and new scientific information. For efficiency and practical purposes, the re-
evaluation should, as far as possible, be conducted by group of food additives according to the main
functional class to which they belong.
The order of priorities for the re-evaluation of the currently approved food additives should be set
on the basis of the following criteria: the time since the last evaluation of a food additive by the
Scientific Committee on Food (SCF) or by EFSA, the availability of new scientific evidence, the extent
of use of a food additive in food and the human exposure to the food additive taking also into account
the outcome of the Report from the Commission on Dietary Food Additive Intake in the EU3 of 2001.
The report “Food additives in Europe 20004 “submitted by the Nordic Council of Ministers to the
Commission, provides additional information for the prioritisation of additives for re-evaluation. As
colours were among the first additives to be evaluated, these food additives should be re-evaluated
with a highest priority.
In 2003, the Commission already requested EFSA to start a systematic re-evaluation of authorised
food additives. However, as a result of adoption of Regulation (EU) 257/2010 the 2003 Terms of
References are replaced by those below
1.1.2. Terms of Reference
The Commission asks the European Food Safety Authority to re-evaluate the safety of food
additives already permitted in the Union before 2009 and to issue scientific opinions on these
additives, taking especially into account the priorities, procedures and deadlines that are enshrined in
the Regulation (EU) No 257/2010 of 25 March 2010 setting up a programme for the re-evaluation of
approved food additives in accordance with the Regulation (EC) No 1333/2008 of the European
Parliament and of the Council on food additives.
1.2. Information on existing authorisations and evaluations
Dimethyl polysiloxane is authorised as a food additive in the EU in accordance with Annex II and
Annex III to Regulation (EC) No 1333/2008 on food additives and its specifications are defined in the
Commission Regulation (EU) No 231/2012.5
Dimethyl polysiloxane was first evaluated by JECFA in 1969 and again in 1974 when an acceptable
daily intake (ADI) of 0–1.5 mg/kg bw was derived, based on an NOAEL of 150 mg/kg bw per day from
a long-term toxicity rat study performed in 1959 (JECFA, 1974, 1975).
1 Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives. OJ L
354, 31.12.2008.
2 Commission Regulation (EU) No 257/2010 of 25 March 2010 setting up a programme for the re-evaluation of approved food
additives in accordance with Regulation (EC) No 1333/2008 of the European Parliament and of the Council on food additives.
OJ L 80, 26.3.2010, p. 19–27.
3 COM(2001) 542 final.
4 Food Additives in Europe 2000, Status of safety assessments of food additives presently permitted in the EU, Nordic Council of
Ministers, TemaNord 2002, 560.
5 Commission Regulation (EU) No 231/2012 of 9 March 2012 laying down specifications for food additives listed in Annexes II
and III to Regulation (EC) no 1333/2008 of the European Parliament and of the Council. OJ L 83, 22.3.2012.
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In 1979, JECFA specified that the previously established ADI of 0–1.5 mg/kg bw applied only to
compounds with 200–300 subunits and not to compounds with a relative molecular mass in the range
of 200 to 300 as previously stated. The average molecular mass was also corrected to be in the range
of 15,000 to 22,000. The viscosity was specified to be in the range of 100 to 1,500 centistokes (JECFA,
1980). No toxicological monograph was prepared.
In 1990, the JECFA specifications were revised to include material with a range of 90–410 subunits
and an average molecular mass of 6,800–30,000, but no toxicological evaluation was performed
(JECFA, 1991).
In 2008, the substance was again on the agenda of JECFA and the ADI of 0–1.5 mg/kg bw
previously established was withdrawn and an additional safety factor of 2 was included to establish a
temporary ADI of 0–0.8 mg/kg bw because of effects on the cornea of test animals in new studies
evaluated by the Committee. An addendum to the toxicological monograph was prepared (JECFA,
2009).
In 2011, JECFA considered new studies and concluded that the ocular lesions were caused by local
toxicity when the eyes of laboratory animals were exposed to dimethyl polysiloxane through contact with
the substance in feed or faeces or through grooming of contaminated fur. The Committee therefore
re-established an ADI of 0–1.5 mg/kg bw per day (JECFA, 2011a). No monograph was prepared.
In 1990, the SCF evaluated dimethyl polysiloxane and agreed with the ADI of 1.5 mg/kg bw per
day established by JECFA in 1974 (SCF, 1991).
ANSES has published a series of opinions on the use, as processing aids, of various anti-foaming
agents, including dimethyl polysiloxane (ANSES, 2017a,b,c). ANSES emphasised that the database was
extremely limited quantitatively and qualitatively. Due to low use levels as processing aid, exposure
levels were determined to be low (from 0.2 to 22% percent of the ADI of 1.5 mg/kg bw per day), and
ANSES concluded there was no safety concern.
In the EU, dimethyl polysiloxane (substance number: 575, reference number: 76721, CAS Registry
Number: 63148-62-9, molecular weight: > 6,800 Da, viscosity: not less than 100 centistokes at 25°C) is
furthermore permitted for plastics in contact with food according to Commission Regulation (EU) 10/2011.6
A specific migration limit is not defined.
Furthermore, dimethyl polysiloxane (dimethicone, CAS No 63148-62-9, 9006-65-9 or 9016-00-6) is
permitted as an antifoaming agent, as an emollient, for use in skin conditioning and for skin
protection, in cosmetic products (European Commission database-CosIng.7)
2. Data and methodologies
Data
The FAF Panel was not provided with a newly submitted dossier. EFSA launched public calls for
data8,9 to collect information from interested parties.
The Panel based its assessment on information submitted to EFSA following the public calls for
data, information from previous evaluations and additional available literature up to March 2020.
Attempts were made at retrieving relevant original study reports on which previous evaluations or
reviews were based, however not always these were available to the Panel.
Food consumption data used to estimate the dietary exposure to dimethyl polysiloxane (E 900)
were derived from the EFSA Comprehensive European Food Consumption Database (Comprehensive
Database10).
The Mintel Global New Products Database (GNPD) was used to verify the use of dimethyl
polysiloxane (E 900) in food and beverage products and food supplements within the EU’s food
market. The Mintel GNPD is an online database that contains the compulsory ingredient information
present on the label of numerous products.
6 Commission Regulation (EU) No 10/2011 of 14 January 2011 on plastic materials and articles intended to come into contact
with food. OJ L 12, 15.1.2011, p. 1–89.
7 Available online: http://ec.europa.eu/consumers/cosmetics/cosing/index.cfm?fuseaction=search.simple
8 Call for scientific data on miscellaneous food additives permitted in the EU and belonging to several functional classes.
Published: 15 June 2012. Available from: https://www.efsa.europa.eu/sites/default/files/consultation/120215.pdf
9 Call for food additives usage level and/or concentration data in food and beverages intended for human consumption (Batch 5).
Available from: https://www.efsa.europa.eu/sites/default/files/consultation/160524.pdf
10 Available online: http://www.efsa.europa.eu/en/datexfoodcdb/datexfooddb.htm
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Methodologies
This opinion was formulated following the principles described in the EFSA Guidance on
transparency with regard to scientific aspects of risk assessment (EFSA Scientific Committee, 2009)
and following the relevant existing guidance documents from the EFSA Scientific Committee.
The FAF Panel assessed the safety of dimethyl polysiloxane (E 900) as a food additive in line with
the principles laid down in Regulation (EU) 257/2010 and in the relevant guidance documents:
Guidance on submission for food additive evaluations by the SCF (2001) and taking into consideration
the Guidance for submission for food additive evaluations in 2012 (EFSA ANS Panel, 2012).
When in animal studies, the test substance was administered in the feed or in drinking water, but
doses were not explicitly reported by the authors as mg/kg bw per day based on actual feed or water
consumption, the daily intake is calculated by the Panel using the relevant default values. In case of
rodents, the values as indicated in the EFSA Scientific Committee Guidance document (EFSA Scientific
Committee, 2012) are applied. In the case of other animal species, the default values by JECFA (2000)
are used. In these cases, the dose was expressed as ‘equivalent to mg/kg bw per day’.
Dietary exposure to dimethyl polysiloxane (E 900) from its use as a food additive was estimated
combining the food consumption data available within the EFSA Comprehensive Database with the
maximum permitted levels (MPLs) and reported use levels submitted to EFSA following a call for data.
The exposure was estimated according to different exposure scenarios. Uncertainties in the exposure
assessment were identified and discussed.
3. Assessment
3.1. Technical data
3.1.1. Identity of the substance
According to Commission Regulation (EU) 231/2012, dimethyl polysiloxane (E 900) is a mixture of
fully methylated linear siloxane polymers containing repeating units of the formula (CH3)2SiO and
stabilised with trimethylsiloxy end-blocking units of the formula (CH3)3SiO. Its chemical formula is
(CH3)3-Si-[O-Si(CH3)2]n-O-Si(CH3)3. The chemical name reported is ‘siloxanes and silicone, dimethyl’
and as synonyms: polydimethyl siloxane; PDMS; silicone fluid; silicone oil; dimethyl silicone.
According to JECFA specifications for polymethylsiloxane (2011b), the molecular weights of the
linear polymers range from approximately 6,800–30,000 Da, its chemical name is a-(trimethylsilyl)-x-
methylpoly(oxy(dimethylsilylene)) and its CAS Registry Number is 9006-65-9.
According to industry (Documentation provided to EFSA No 5), the CAS No 63148-62-9 is
commonly used for dimethyl polysiloxane and it is preferable to CAS No 9006-65-9 which is used for
dimethicone. Both CAS numbers represent the same substance; from the ECHA inventory, the name
‘dimethicone’ has both CAS numbers. This is also the case in the European Commission database for
cosmetic ingredients. For CAS No 63148-62-9, the EC No is 613-156-5.
The structural formula of dimethyl polysiloxane is given in Figure 1.
The Panel noted that the name ‘dimethyl polysiloxane’ is not precise for the material and ‘poly
(dimethylsiloxane)’ would be a more accurate name.
According to industry (Documentation provided to EFSA No.5), monodisperse dimethyl polysiloxane
nanoparticles are not used as a food additive E 900.
Figure 1: Structural formula of dimethyl polysiloxane (JECFA, 2011b)
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3.1.2. Specifications
Specifications have been defined in Commission Regulation (EU) No 231/2012 and by JECFA
(2011b) (see Table 1).
The Panel noted that, according to the EU specifications for dimethyl polysiloxane (E 900),
impurities of the toxic elements arsenic, lead and mercury are accepted up to concentrations of 3, 1
and 1 mg/kg, respectively. Contamination at those levels could have a significant impact on the
exposure, which are already close to the health-based guidance values or benchmark doses (lower
confidence limits) established by EFSA (EFSA CONTAM Panel, 2009, 2010, 2012a,b, 2014).
Analytical certificates/specifications for commercial products of dimethyl polysiloxane manufactured
by three companies were submitted by the interested parties (Documentation provided to EFSA No. 6).
Company A provided data for two formulations having a viscosity of either 350 or 1000 cst. In all
cases, the data from three batches from these formulations met the current EU specifications for
dimethyl polysiloxane (E 900). Results on arsenic, lead and mercury were all reported as not detected
with limits of detection (LOD) being 0.5, 0.5 and 0.3 mg/kg, respectively. Company B provided data on
colour, transparency, odour, viscosity and refractive index for four lots with viscosity of 100 cst, which
all fulfil the EU requirements. According to the data provider, these criteria are determined for each lot.
Other parameters are termed ‘guaranteed values’, such as maximum limits for arsenic of 2 mg/kg and
Table 1: Specifications established for dimethyl polysiloxane (E 900) according to Commission
Regulation (EU) No 231/2012 and for polydimethylsiloxane (INS 900a) according to JECFA
(JECFA, 2011b)
Commission Regulation 231/2012 JECFA (2011b)
Definition Dimethyl polysiloxane is a mixture of fully
methylated linear siloxane polymers
containing repeating units of the formula
(CH3)2SiO and stabilised with trimethylsiloxy
end-blocking units of the formula (CH3)3SiO
Polydimethylsiloxane consists of fully
methylated linear siloxane polymers containing
repeating units of the formula [(CH3)2SiO]
with trimethylsiloxy end-blocking units of the
formula (CH3)3SiO-. The additive is produced
by hydrolysis of a mixture of
dimethyldichlorosilane and a small quantity of
trimethylchlorosilane. The average molecular
weights of the linear polymers range from
approximately 6,800 to 30,000
Assay Content of total silicon not less than 37.3%
and not more than 38.5%
Silicon content not less than 37.3% and not
more than 38.5% of the total




Between 0.964 and 0.977 0.964–0.977
Refractive index [n]D




The infrared absorption spectrum of a liquid
film of the sample between two sodium
chloride plates exhibits relative maxima at the
same wavelengths as those of a similar
preparation of dimethyl polysiloxane
Reference Standard
The infrared absorption spectrum of a liquid
film of the sample between two sodium
chloride plates exhibits relative maxima at the
same wavelengths as those of a similar
preparation of USP dimethyl polysiloxane
Reference Standard




Loss on drying Not more than 0.5% (150 °C, 4 h) Not more than 0.5% (150 °C, 4 h)
Viscosity Not less than 1.00 10  4 m2s1 at 25 °C
[equivalent to 100 centistokes]
100 – 1,500 centistokes at 25 °C
Arsenic Not more than 3 mg/kg –
Lead Not more than 1 mg/kg Not more than 1 mg/kg
Mercury Not more than 1 mg/kg –
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for ‘heavy metal’ of 20 mg/kg, without further specification. Company C provided certificates on two
commercial products with 350 and 1000 cst, respectively. Data on basic parameters meet the current
EU specifications. No results on toxic elements were provided. The Panel noted that, based on the
analytical data provided by Company A, lowering of the EU specifications for toxic elements is possible.
The Panel noted that, in the JECFA specifications (2011b), a range of 6,800–30,000 for the average
molecular weight is defined for dimethyl polysiloxane used as a food additive, while a limit is not
included in the EU specifications. In addition, a maximum limit of 1,500 centistokes (25°C) for the
viscosity is also specified in the JECFA specifications. Information on weight average molecular weight
(Mw) of approximately 20,000 and 33,000 and number average molecular weight (Mn) of
approximately 11,000 and 16,000 for dimethyl polysiloxane with 350 and 1000 cst, respectively, have
been provided (Documentation provided to EFSA No 6).
The Panel noted that cyclopolysiloxanes can be formed during the manufacturing process. Although
they are volatile, they could contaminate the final product. Several publications have reported that
some of the cyclopolysiloxanes may have toxic effects including endocrine-disrupting activity (Helms
et al., 2018; Helms et al., 2019), associated with oestrogenic effects in vitro and in vivo (Quinn et al.,
2007), and increase endometrial hyperplasia and uterine adenocarcinomas in rats (Jean et al., 2016,
2017b; Jean and Plotzke, 2017a). The Panel considered that cyclopolysiloxanes should not be present
in the food additive dimethyl polysiloxane E 900.
3.1.3. Manufacturing process
According to information provided by industry (CEFIC-CES, 2012, Dow-Corning-Corporation, 2005,
Documentation provided to EFSA No 5), the starting material for the manufacturing of dimethyl
polysiloxanes is pure silicon obtained from quartz sand after heating under high temperature.
In a following step, the silicon powder is reacted with methyl chloride (CH3Cl) at high temperature
(200°C–300°C) and under high pressure (100–500 kPa). The reaction is catalysed by a copper-based
catalyst and generates different methyl chlorosilanes.
It was stated that the copper catalyst is a volatile compound (Dow-Corning-Corporation, 2005,
Documentation provided to EFSA No. 25). However, in the absence of information on the nature of this
catalyst, the Panel considered that a limit for copper should be included in the EU specifications.
The general reaction scheme is as follows:
xSiþ yCH3Cl ! methyl chlorosilanes
In the resulted mixture of chlorosilanes, dimethyldichlorosilane [(CH3)2SiCl2] is present with the
highest mass fraction. Pure dimethyldichlorosilane is separated from the mixture of chlorosilanes by
distillation.
Dimethyldichlorosilane is hydrolysed, giving rise to a mixture of cyclic dimethyl polysiloxanes (with
3–6 repeating SiO units) and linear chains (with 30–50 repeating SiO units). This mixture separates
from the aqueous acid phase, the ratio between the cyclic and linear oligomers depending on the
hydrolysis conditions (concentrations, pH, solvents).
The general reaction scheme is as follows:
Linear chains are polymerised under acidic catalysis until the desired viscosity is obtained.
In the case of the cyclic starting material, the rings open under acid catalysis and the resulting
linear chains polymerise, under controlled conditions, to the desired viscosity. The catalyst and the low
molecular weight species are removed by distillation at high temperature and under low pressure
(< 1 mbar). The removal of traces of catalyst is an important step in the manufacturing of dimethyl
polysiloxane (Dow-Corning-Corporation, 2005, Documentation provided to EFSA No 25).
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Finally, a process called ‘end blocking’ is used to control chain length, molecular weight and
viscosity.
The silicone fluid with the desired viscosity is filtered to remove impurities.
No analytical data demonstrating the absence of starting materials or intermediate products (e.g.
dimethyldichlorosilane/dimethylsilanediol/CH3SiOSiCH3/CH3SiOH) in the final product was available, but
according to the information available on the production process, the Panel considered that they are
not expected to be present.
3.1.4. Methods of analysis in food
Flame atomic absorption spectrometry has been used for the determination of dimethyl
polysiloxane in fats and oils (Doeden et al., 1980; McCamey et al., 1986) and for estimation of the
amount of dimethyl polysiloxane taken up by food fried in a dimethyl polysiloxane-containing oil
(Freeman et al., 1973).
Solvent extraction combined with flame atomic absorption spectroscopy was used for the
determination of dimethyl polysiloxane in fruit juices and beer (Kacprzak, 1982; Parker, 1990; Gooch,
1993).
Infrared absorption spectroscopy was used to determine, after extraction, dimethyl polysiloxane in
pineapple and in vegetables processed with silicone antifoams (e.g. bread, waffles, hydrolysed
vegetable protein and frozen vegetables) (Horner et al., 1960).
1H-nuclear magnetic resonance has been used for the determination of dimethyl polysiloxane in
wine and edible oils (Mojsiewicz-Pienkowska et al., 2003).
Size exclusion chromatography with evaporative light scattering detection was described and tested
experimentally to separate and determine molecular weights of linear dimethyl polysiloxanes
(Mojsiewicz-Pienkowska, 2008).
An overview of the fractionation methods for various silicones (including dimethyl polysiloxane) are
described by Mojsiewicz-Pienkowska and Lukasiak (2003). In addition, a review of the determination of
silicones in biological matrices is provided by Cavic-Vlasak et al. (1996).
3.1.5. Stability of the substance, and reaction and fate in food
The following information was provided by the interested parties (Documentation provide to EFSA,
2010), dimethyl polysiloxane’s molecular backbone structure consists of alternating silicon and oxygen
atoms and breaking the Si-O-bonds requires comparatively high activation energy (Andriot et al. 2007;
Kendrick et al. 1989). The ECETOC monograph (2011; 2nd edition) states that dimethyl polysiloxanes
are chemically stable substances showing a remarkable resistance to thermal and oxidative
degradation and radiation. Dry heat of 150°C is considered to have little effect in that only traces of
formaldehyde can be detected from reaction of oxygen with the methyl groups. Wet heat (steam) at
120°C or higher causes depolymerisation. Strong acids or bases attack the Si-O-Si bonds. Siloxane
structures of varying molecular sizes are formed, traces of the catalyst may also induce this
depolymerisation reaction (see also Kucera and Lanikova, 1961). The removal of traces of catalyst is
an important step in the manufacturing of dimethyl polysiloxane (Dow-Corning-Corporation, 2005,
Documentation provided to EFSA No 25). Depolymerisation of dimethyl polysiloxane is observed at
high temperatures: the molecular chains are stable up to at least 300–450°C, complete pyrolysis is
observed at temperatures of at least 500°C (Kendrick et al. 1989). Freeman et al. (1973) investigated
the effects of frying potatoes chips in oil containing 2 mg/kg silicone or more. They observed a
reduction of the dimethyl polysiloxane concentration in the oil; the dimethyl polysiloxane was absorbed
by the potato chips. Totani et al. (2018) investigated the protective effect of dimethyl polysiloxane on
canola oil during deep frying of potatoes at 180°C, for 6 h continuously or with 10-, 20-, or 30-min
intervals between frying sessions. The total polar compounds content (TPC) of the oil was used as
indicator value for oil stability. A superior protective effect of PDMS on the frying oil was observed
regardless of the deep-frying pattern employed.
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In conclusion, the data on the chemical properties and stability of dimethyl polysiloxane indicated
that the food additive will be stable in foods at the typical acidic and alkaline conditions present in
food. Though dimethyl polysiloxane as such may depolymerise at temperatures above approximately
300°C, such reactions have not been observed and are not expected when frying foods in oils that
contain dimethyl polysiloxane.
3.2. Authorised uses and use levels
Maximum levels of dimethyl polysiloxane (E 900) in foods have been defined in Annex II to
Regulation (EC) No 1333/200811 on food additives, as amended. In this document, these levels are
named MPLs.
Currently, dimethyl polysiloxane (E 900) is an authorised food additive, used as an antifoaming
agent in foods, in the EU with MPLs ranging from 10 to 100 mg/kg in 14 food categories as set by
Annex II to Regulation (EC) No 1333/2008 (Table 2).
According to Annex III, Part 1 of Regulation (EC) No 1333/2008, dimethyl polysiloxane (E 900) is
also authorised as a carrier in glazing agents for fruit at quantum satis (QS).
According to Annex III, Part 2 of Regulation (EC) No 1333/2008, dimethyl polysiloxane (E 900) is
also authorised as a food additive in colour preparations of E 160a carotenes, E 160b annatto, bixin,
Table 2: MPLs of dimethyl polysiloxane (E 900) in food categories according to the Annex II to











02.1 Fats and oils essentially free from water
(excluding anhydrous milk fat)
E 900 only oils and fats
for frying
10
02.2.2 Other fat and oil emulsions including
spreads as defined by Council Regulation
(EC) No 1234/2007 and liquid emulsions
E 900 only oils and fats
for frying
10
04.2.3 Canned or bottled fruit and vegetables E 900 10
04.2.5.2 Jam, jellies and marmalades and
sweetened chestnut puree as defined by
Directive 2001/113/EC
E 900 10
04.2.5.3 Other similar fruit or vegetable spreads E 900 10
05.2 Other confectionery including breath
freshening microsweets
E 900 10
05.3 Chewing gum E 900 100
05.4 Decorations, coatings and fillings, except
fruit-based fillings covered by category
4.2.4
E 900 10
06.6 Batters E 900 10
12.5 Soups and broths E 900 10
14.1.2 Fruit juices as defined by Directive 2001/
112/EC and vegetable juices




14.1.4 Flavoured drinks E 900 10
14.2.3 Cider and perry E 900 excluding cidre
bouche
10
17.1 Food supplements supplied in a solid
form, excluding food supplements for
infants and young children





MPL: maximum permitted level.
(a): Maximum level applies to the dissolved food supplement ready for consumption when diluted with 200 ml of water.
11 Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives. OJ L
354, 31.12.2008, p. 16.
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norbixin, E 160c Paprika extract, capsanthin, capsorubin, E 160d lycopene and E 160e beta-apo-80-
carotenal with a maximum level of 200 mg/kg in the preparation and 0.2 mg/L in the final food.
According to Annex III, Part 4 of Regulation (EC) No 1333/2008, dimethyl polysiloxane (E 900) is
also authorised as a food additive in all food flavourings at a maximum level of 10 mg/kg in
flavourings.
In addition, according to Annex III, Part 5, Section A, of Regulation (EC) No 1333/2008, dimethyl
polysiloxane (E 900) is also authorised as a food additive in preparations of beta-carotene and
lycopene with a maximum level of 200 mg/kg in the preparation and 0.2 mg/L in the final food.
3.3. Exposure data
3.3.1. Reported use levels or data on analytical levels of dimethyl polysiloxane
(E 900)
Most food additives in the EU are authorised at a specific MPL. However, a food additive may be
used at a lower level than the MPL. Therefore, information on actual use levels is required for
performing a more realistic exposure assessment.
In the framework of Regulation (EC) No 1333/2008 on food additives and of Commission
Regulation (EU) No 257/2010 regarding the re-evaluation of approved food additives, EFSA issued a
public call12 for occurrence data (usage level and/or analytical data) on dimethyl polysiloxane (E 900).
In response to this public call, industry provided updated information on the use levels of dimethyl
polysiloxane (E 900) in foods to EFSA. No analytical data on the concentration of dimethyl polysiloxane
(E 900) in foods were provided by the Member States.
Summarised data on reported use levels in foods provided by industry
Industry provided EFSA with 28 use levels of dimethyl polysiloxane (E 900) in foods for three out of
the 14 food categories (FCs) in which dimethyl polysiloxane (E 900) is authorised. Most of these use
levels were for the use of dimethyl polysiloxane (E 900) in FC 02.1 Fats and oils essentially free from
water (excluding anhydrous milkfat (n = 10) and FC 14.1.4 Flavoured drinks (n = 11).
In addition, four use levels of dimethyl polysiloxane (E 900) were provided for two food categories
in which dimethyl polysiloxane (E 900) is not authorised to be added directly, but due to Annex III
authorisation (present due to carry-over): FC 04.1.1 Entire fresh fruit and vegetables (n = 1) and FC
08.2 Meat preparations as defined by Regulation (EC) No 853/2004 (n = 3). These levels were
included in the analysis.
The use levels of dimethyl polysiloxane (E 900) in foods were provided by Spanish Association of
Postharvest Services and Processes (AGRUPOST), Food Drink Europe (FDE), the European Margarine
Association (IMACE) and FEDIOL – The EU Vegetable Oil and Protein meal Industry Association
(FEDIOL).
In total, 14 use levels of dimethyl polysiloxane (E 900) referred to niche products. These levels, 11
for flavoured drinks (FC 14.1.4) and three for meat preparations as defined by Regulation (EC) No
853/2004 (FC 08.2), were included in the analysis as no other use levels were available for these food
categories.
Appendix A provides the use levels of dimethyl polysiloxane (E 900) in foods as reported by
industry.
3.3.2. Summarised data extracted from the Mintel’s Global New Products
Database
The Mintel GNPD is an online database which monitors new introductions of packaged goods in the
market worldwide. It contains information of over 3 million food and beverage products of which more
than 1,100,000 are or have been available on the European food market. Mintel started covering EU’s
food markets in 1996, currently having 24 out of its 27 member countries, Norway and UK presented
in the Mintel GNPD.13
12 https://www.efsa.europa.eu/en/data/call/160524
13 Missing Bulgaria, Cyprus, Estonia, Latvia, Lithuania, Luxembourg, Malta and Slovenia.
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For the purpose of this scientific opinion, Mintel’s GNPD14 was used for checking the labelling of
food and beverage products and food supplements for dimethyl polysiloxane (E 900) within the EU
food market as the database contains the compulsory ingredient information on the label.
According to Mintel’s GNPD, dimethyl polysiloxane (E 900) was labelled on 111 products in the last
5 years. These products belong to different Mintel subcategories. The two subcategories with the highest
percentage of food products labelled with dimethyl polysiloxane (E 900) within the subcategory were
‘Sports Drinks’ (1%) and ‘Shortening & Lard’ (0.8%). For a complete overview of the percentages per
subcategory with at least one food labelled with dimethyl polysiloxane (E 900), see Appendix B. The
average percentage of foods labelled to contain dimethyl polysiloxane (E 900) in these subcategories
was 0.08%.
3.3.3. Food consumption data used for exposure assessment
EFSA Comprehensive European Food Consumption Database
Since 2010, the EFSA Comprehensive European Food Consumption Database (Comprehensive
Database) has been populated with national data on food consumption at a detailed level. Competent
authorities in European countries provide EFSA with data on the level of food consumption by the
individual consumer from the most recent national dietary survey in their country (cf. Guidance of
EFSA on the ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure
Assessment’ (EFSA, 2011a). Consumption surveys added in the Comprehensive database in 2015 were
also taken into account in this assessment.10
The food consumption data gathered by EFSA were collected by different methodologies and thus
direct country-to-country comparisons may not be appropriate. Depending on the food category and
the level of detail used for exposure calculations, uncertainties could be introduced owing to possible
subjects’ underreporting and/or misreporting of the consumption amounts. Nevertheless, the
Comprehensive Database includes the currently best available food consumption data across Europe.
Food consumption data of infants, toddlers, children, adolescents, adults and the elderly were used
for the exposure assessment. For the present assessment, food consumption data were available from
33 different dietary surveys carried out in 19 European countries (Table 3).
Consumption records are codified according to the FoodEx classification system (EFSA, 2011b).
Nomenclature from the FoodEx classification system has been linked to the food categorisation system
Table 3: Population groups considered for the exposure estimates of dimethyl polysiloxane (E 900)
Population Age range
Countries with food consumption surveys covering
more than 1 day
Infants From more than 12 weeks up to
and including 11 months of age
Bulgaria, Denmark, Finland, Germany, Italy, UK
Toddlers(a) From 12 months up to and
including 35 months of age
Belgium, Bulgaria, Denmark, Finland, Germany, Italy,
Netherlands, Spain, UK
Children(b) From 36 months up to and
including 9 years of age
Austria, Belgium, Bulgaria, Czech Republic, Denmark,
Finland, France, Germany, Greece, Italy, Latvia, Netherlands,
Spain, Sweden, UK
Adolescents From 10 years up to and including
17 years of age
Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland,
France, Germany, Italy, Latvia, Netherlands, Spain, Sweden,
UK
Adults From 18 years up to and including
64 years of age
Austria, Belgium, Czech Republic, Denmark, Finland, France,
Germany, Hungary, Ireland, Italy, Latvia, Netherlands,
Romania, Spain, Sweden, UK
The elderly(b) From 65 years of age and older Austria, Belgium, Denmark, Finland, France, Germany,
Hungary, Ireland, Italy, Romania, Netherlands, Sweden, UK
(a): The term ‘toddlers’ in the Comprehensive Database (EFSA, 2011a) corresponds to ‘young children’ in Regulations (EC)
No 1333/2008 and (EU) No 609/2013.
(b): The terms ‘children’ and ‘the elderly’ correspond, respectively, to ‘other children’ and the merge of ‘elderly’ and ‘very elderly’
in the Comprehensive Database (EFSA, 2011a).
14 http://www.gnpd.com/sinatra/home/accessed on 20/12/2019
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(FCS) as presented in Annex II of Regulation (EC) No 1333/2008, part D, to perform exposure
assessments. In practice, the FoodEx food codes were matched to the FCS food categories.
Food categories considered for the exposure assessment of dimethyl polysiloxane (E 900)
The food categories in which the use of dimethyl polysiloxane (E 900) is authorised according to
Annex II to Regulation (EC) No 1333/2008 were selected from the nomenclature of the Comprehensive
Database (FoodEx classification system), at the most detailed level possible (up to FoodEx Level 4) (EFSA,
2011b). The two food categories for which use levels were reported for dimethyl polysiloxane (E 900)
according to Annex III to Regulation (EC) No 1333/2008 (FC 04.1.1 Entire fresh fruit and vegetables and
FC 08.2 Meat preparations as defined by Regulation (EC) No 853/2004) were also selected.
Some food categories or their restrictions/exceptions are not referenced in the Comprehensive
Database and could therefore not be considered in the present exposure assessment. This was the
case for two food categories (Appendix C) and may have resulted in an underestimation of the
exposure. These food categories were (in ascending order of the FCS codes):
• 06.6 Batters. Not taken into account as not referenced in the Comprehensive Database.
• 14.1.2 Fruit juices as defined by Directive 2001/112/EC25 and vegetable juices, only Sød . . .
saft and sødet . . . saft, and pineapple juice. Only pineapple juice was included in the exposure
assessment, as Sød . . . saft and sødet . . . saft are not referenced in the FoodEx system.
For the following food categories, the restrictions/exceptions that apply to the use of dimethyl
polysiloxane (E 900) could not be considered, and therefore the whole food category was included in
the exposure assessment. This applied to five food categories (Appendix C) and may have resulted in
an overestimation of the exposure. These food categories were (in ascending order of the FCS codes):
• 02.1 Fats and oils essentially free from water (excluding anhydrous milkfat), only oils and fats
for frying. Considering that it is not possible to select only the consumption of oils and fats for
frying and that many oils and fats can be used for baking, the full food category was
considered.
• 02.2.2 Other fat and oil emulsions, including spreads as defined by Council Regulation (EC)
No 1234/200715 and liquid emulsions, only oils and fats for frying. Considering that it is not
possible to select only the consumption of oils and fats for frying and that many oils and fats
can be used for baking, the full food category was considered.
• 04.2.3 Canned or bottled fruit or vegetable. The category of canned fruit is available in the
FoodEx nomenclature and was selected. Concerning the vegetables, as there is no category of
canned vegetables, only vegetables which can usually be canned were considered, including:
o Cultivated Fungi,
o Legumes, beans, green, without pods: green beans, green peas and green lentils,
o Sweet corn.
• 14.2.3 Cider and perry, excluding cidre bouche. The full food category was considered because
the exception represents a small part of the whole food category.
• 17.1 Food supplements supplied in a solid form, excluding food supplements for infants and
young children, only food supplements in effervescent tablet form. The full FC 17 was taken
into account, because the form cannot be differentiated in the Comprehensive Database. This
food category was only considered in the ‘food supplements consumers only’ scenario.
Overall, 15 food categories were included in the regulatory maximum level exposure assessment
scenario, including the two food categories for which use levels were reported for dimethyl
polysiloxane (E 900) due to Annex III authorisation (Appendix C).
For the refined scenario, five food categories were considered based on use levels for three food
categories authorised according to Annex II and two food categories authorised according to Annex III
(Appendix C). The use level for one of these two food categories was for a niche product belonging to
FC 08.2. Meat preparations as defined by Regulation (EC) No 853/2004, namely chicken preparations
(Appendix A). This use level was applied to all foods categorised in FC 08.2 and could therefore have
resulted in an overestimation of the exposure to dimethyl polysiloxane (E 900) in the refined scenarios.
The Panel noted that this also applied to the regulatory maximum level exposure assessment scenario.
15 Council Regulation (EC) No 1234/2007 of 22 October 2007 establishing a common organisation of agricultural markets and on
specific provisions for certain agricultural products. OJ L 299, 16.11.2007, p. 1.
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3.4. Exposure estimates
3.4.1. Exposure to dimethyl polysiloxane (E 900) from its use as a food additive
The Panel estimated the chronic dietary exposure to dimethyl polysiloxane (E 900) for the following
population groups: infants, toddlers, children, adolescents, adults and the elderly. Dietary exposure to
dimethyl polysiloxane (E 900) was calculated by multiplying concentrations of dimethyl polysiloxane
(E 900) per food category (Appendix D) with their respective consumption amount per kilogram body
weight for each individual in the Comprehensive Database. The exposure per food category was
subsequently added to derive an individual total exposure per day. These exposure estimates were
averaged over the number of survey days, resulting in an individual average exposure per day for the
survey period. Dietary surveys with only 1 day per subject were excluded as they are considered not
adequate to assess repeated exposure.
The exposure was estimated in this way for all individuals per survey and per population group,
resulting in distributions of individual exposure per survey and population group (Table 3). Based on
these distributions, the mean and 95th percentiles of exposure were calculated per survey and per
population group. The 95th percentile of exposure was only calculated for those population groups
with a sufficiently large sample size (EFSA, 2011a). Therefore, in the present assessment, the 95th
percentile of exposure for infants from Italy and for toddlers from Belgium, Italy and Spain was not
estimated.
The exposure to dimethyl polysiloxane (E 900) was estimated based on two different sets of
concentration data: (1) MPLs as set down in Annex II to Regulation (EC) No 1333/2008 (defined as the
regulatory maximum level exposure assessment scenario); and (2) reported use levels (defined as the
refined exposure assessment scenario). To also consider the possible additional exposure from the presence
of dimethyl polysiloxane (E 900) Annex III authorisation in the regulatory maximum level exposure
assessment scenario, the reported use levels for dimethyl polysiloxane (E 900) for FC 04.1.1 Entire fresh fruit
and vegetables and FC 08.2 Meat preparations as defined by Regulation (EC) No 853/2004) were also
included in this scenario. The two scenarios are discussed in detail below.
These scenarios do not consider exposure to dimethyl polysiloxane (E 900) through the intake of
food supplements. This source of exposure was covered in an additional scenario detailed below (food
supplements consumers only scenario). The possible additional exposure from its use in accordance
with Annex III to Regulation (EC) No 1333/2008 was only considered for the food categories for which
use levels were provided.
Regulatory maximum level exposure assessment scenario
The regulatory maximum level exposure assessment scenario of dimethyl polysiloxane (E 900) was
based on the MPLs as set in Annex II to Regulation (EC) No 1333/2008 and listed in Table 2 and use
levels for two food categories in accordance with Annex III to Regulation (EC) No 1333/2008.
The Panel considers the exposure estimates derived following this scenario as the most
conservative since it is assumed that that the population will be exposed to the food additive present
in food at the MPL over a longer period of time.
Refined exposure assessment scenario
The refined exposure assessment scenario of dimethyl polysiloxane (E 900) was based on use
levels reported by food industry. This exposure scenario considers only those food categories for which
these data were provided to the Panel.
Appendix C summarises the use levels of dimethyl polysiloxane (E 900) used in the refined
exposure assessment scenario. Based on the available data set, the Panel calculated two refined
exposure estimates based on two model populations:
• The brand-loyal consumer scenario: It was assumed that a consumer is exposed long-term to
dimethyl polysiloxane (E 900) present at the maximum reported use level for one food
category. This exposure estimate is calculated as follows:
– Combining food consumption data with the maximum of the reported use levels for the
main contributing food category at the individual level.
– Using the mean of the typical reported use levels for the remaining food categories.
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• The non-brand-loyal consumer scenario: It was assumed that a consumer is exposed long
term to dimethyl polysiloxane (E 900) present at the mean of the typical reported use levels in
food for all food categories.
Exposure assessment for ‘Food supplement consumers only’ scenario
Dimethyl polysiloxane (E 900) is authorised in FC 17 Food supplements as defined in Directive
2002/46/EC excluding food supplements for infants and young children. As exposure via food
supplements may deviate largely from the one via food, and the number of food supplement
consumers may be low depending on populations and surveys, an additional scenario was calculated in
order to reflect additional exposure to food additives from food supplements. As no use levels were
reported for food supplements, this scenario was estimated using MPLs. For the remaining food
categories (5/13 categories), the mean of the typical reported use levels was used.
As FC 17 does not consider food supplements for infants and toddlers as defined in the legislation,
exposure to dimethyl polysiloxane (E 900) from food supplements was not estimated for these two
population groups.
This scenario included six food categories (Appendix C).
Dietary exposure to dimethyl polysiloxane (E 900)
Table 4 summarises the estimated exposure to dimethyl polysiloxane (E 900) from its use as a food
additive in six population groups (Table 3) for the different exposure scenarios. Detailed results per
population group and survey are presented in Appendix D.
In the regulatory maximum level exposure assessment scenario, mean exposure to dimethyl
polysiloxane (E 900) from its use as a food additive ranged from 0.01 mg/kg bw per day in the elderly
to 0.23 mg/kg bw per day in toddlers. The 95th percentile of exposure to dimethyl polysiloxane
(E 900) ranged from 0.03 mg/kg bw per day in the elderly to 0.51 mg/kg bw per day in toddlers.
In the refined exposure assessment scenario, mean exposure to dimethyl polysiloxane (E 900) from its
use as a food additive ranged from 0.01 mg/kg bw per day in adults and the elderly to 0.16 mg/kg bw per
day in children in the brand-loyal scenario. The high exposure (95th percentile) to dimethyl polysiloxane
(E 900) ranged from 0.02 mg/kg bw per day in the elderly to 0.49 mg/kg bw per day in toddlers. In the
non-brand-loyal scenario, mean exposure to dimethyl polysiloxane (E 900) from its use as a food additive
ranged from 0.01 mg/kg bw per day in infants, children, adolescents, adults and the elderly to 0.06 mg/kg
Table 4: Summary of dietary exposure to dimethyl polysiloxane (E 900) from its use as a food
additive in the regulatory maximum level exposure assessment scenario and in the refined
exposure assessment scenarios, in six population groups (minimum–maximum across the
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bw per day in toddlers. The 95th percentile of exposure to dimethyl polysiloxane (E 900) ranged from
0.02 mg/kg bw per day in adults and the elderly to 0.15 mg/kg bw per day in toddlers.
In the food supplements consumers only scenario, mean exposure to dimethyl polysiloxane (E 900)
from its use as a food additive ranged from 0.01 mg/kg bw per day in adolescents, adults and the elderly
to 0.07 mg/kg bw per day in children. The 95th percentile of exposure to dimethyl polysiloxane (E 900)
ranged from 0.02 mg/kg bw per day in adults and the elderly to 0.10 mg/kg bw per day in children.
Main food categories contributing to exposure to dimethyl polysiloxane (E 900) for the
regulatory maximum level exposure assessment scenario
In the regulatory maximum level exposure assessment scenario, FC 14.1.4 Flavoured drinks was
the main contributing food category to the total mean exposure estimates for all population groups.
Other important food categories contributing to the total mean exposure in this scenario were FC 12.5
Soups and broths (for all population groups except toddlers) and FC 02.1 fats and oils essentially free
from water (excluding anhydrous milkfat).
Main food categories contributing to exposure to dimethyl polysiloxane (E 900) using the
refined exposure assessment scenario
The main contributing food category in the brand-loyal refined exposure assessment scenario was
FC 04.1.1 Unprocessed fruits and vegetables for infants, for children, toddlers and the elderly, while for
children, adolescents and adults, the main contributing food category was FC 14.1.4 Flavoured drinks.
The main contributing food category in the non-brand-loyal refined exposure assessment scenario
was FC 04.1.1 Unprocessed fruits and vegetables for all population groups, except for adolescents for
which FC 14.1.4 Flavoured drinks contributed most to the exposure. (Appendix E).
The Panel identified potential brand loyalty to FC 14.1.4. Flavoured drinks and considered that
dimethyl polysiloxane (E 900) could change the organoleptic properties due to its sweet taste, the
Panel therefore considered the brand-loyal refined estimated exposure scenario as the most
appropriate and realistic scenario for the risk characterisation of dimethyl polysiloxane (E 900).
Uncertainty analysis
Potential sources of uncertainties in the exposure assessment of dimethyl polysiloxane (E 900) have
been presented above. In accordance with the guidance provided in the EFSA opinion related to
uncertainties in dietary exposure assessment (EFSA, 2007), the following sources of uncertainties have
been considered and summarised in Table 5.
Table 5: Qualitative evaluation of influence of uncertainties on the dietary exposure estimate
Sources of uncertainties Direction (a)
Consumption data: different methodologies/representativeness/underreporting/misreporting/no
portion size standard
+/
Methodology used to estimate high percentiles (95th) long-term (chronic) exposure based on
data from food consumption surveys covering only a few days
+
Correspondence of reported use levels to the food items in the Comprehensive Database:
uncertainties to which types of food the levels refer
+/
Uncertainty in possible national differences in use levels of food categories +/
Concentration data:
– use levels considered applicable to all foods within the entire food category, whereas on
average 0.08% of the foods, belonging to Mintel’s food subcategories with at least one
food labelled with the additive, was labelled with the additive
– levels used for flavoured drinks reported for niche products
+
+
The three food categories which were considered in the refined exposure assessment scenarios
out of all authorised food categories according to Annex II to Regulation (EC) No 1333/2008
(n = 14), corresponded to 28% to 99.8% of the amount (g of foods by body weight) of foods
consumed in the Consumption Database that could potentially contain the additive
–
Re-evaluation of dimethyl polysiloxane (E 900)
www.efsa.europa.eu/efsajournal 18 EFSA Journal 2020;18(5):6107
Dimethyl polysiloxane (E 900) is authorised in 14 food categories according to Annex II to
Regulation N°1333/2008 (Table 2). For three of these food categories use levels were provided, as well
as for foods of two food categories in which dimethyl polysiloxane (E 900) is authorised according to
Annex III to Regulation N°1333/2008.
The Panel noted that 14 out of 25 food subcategories, categorised following the Mintel GNPD
nomenclature, in which dimethyl polysiloxane (E 900) was labelled according to the Mintel GNPD were
included in the refined exposure assessment. These 14 food subcategories represented approximately
75% of the food products labelled with dimethyl polysiloxane (E 900) in this database. The label
information of Mintel GNPD does not include all foods in which dimethyl polysiloxane (E 900) will be
used, because the labelling of food additives present due to use according to Annex III is not
mandatory.
The percentage of foods per subcategory labelled to contain dimethyl polysiloxane (E 900) was
maximally about 1% (Appendix B). In the assessment, it was assumed that 100% of the foods
belonging to an authorised food category contained the additive.
Considering the direction of all uncertainties (Table 5), the Panel concluded that the exposure to
dimethyl polysiloxane (E 900) from its use as a food additive according to Annex II for the regulatory
maximum level exposure assessment scenario was overestimated for the European countries
considered in the Comprehensive Database. The refined exposure assessment scenario also led to an
overestimation of the exposure from its use as a food additive according to Annex II, especially
because
• 75% of the food products labelled with dimethyl polysiloxane (E 900) in the Mintel GNPD were
included in the refined scenarios;
• it was assumed that all foods belonging to an authorised food category contained dimethyl
polysiloxane (E 900).
The Panel noted that food categories which may contain dimethyl polysiloxane (E 900) due to
Annex III (Parts 1, 2, 4, 5) authorisation were partially considered in the exposure assessment.
3.4.2. Exposure to dimethyl polysiloxane from uses other than as a food additive
Dimethyl polysiloxane is also used in cosmetic products, as an excipient in pharmaceutical products
and as a processing aid in food. Quantification of exposure via all these sources is not known and was
therefore not considered in this opinion.
3.5. Biological and Toxicological data
The Panel noted that E 900 is a mixture of polymers and the analytical methods used for
characterising the fate of the mixture in mammalians reflects the sum of the toxicokinetics, but not
that of individual components. Even in a study in rats (Dow-Corning-Corporation-Health-And-
Environmental-Sciences 2000, 2001(Documentation provided to EFSA No 24)) in which radiolabelled
substance was administered, the kinetics of any single component were not characterised.
Sources of uncertainties Direction (a)
Food categories selected for the exposure assessment:
– exclusion of food categories due to missing FoodEx linkage (n = 2/14 for MPL scenario)
– inclusion of food categories without considering the restriction/exception (n = 3 MPL
scenario/n = 2 refined scenarios out of 14 food categories)
– no data for certain food categories which were therefore not considered in the exposure




Regulatory maximum level exposure assessment scenario:
– exposure calculations based on the MPL according to Annex II to Regulation (EC)
No 1333/2008 and due Annex III to Regulation (EC) No 1333/2008 authorisation
+
Refined exposure assessment scenarios:
– exposure calculations based on the maximum or mean levels (reported use from
industries)
+/–
(a): +, uncertainty with potential to cause overestimation of exposure; –, uncertainty with potential to cause underestimation of
exposure.
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Biological and toxicological studies performed with dimethyl polysiloxanes that do not comply with
the EU specifications for E 900 with respect to viscosity (below 100 centistokes) have been considered
as complementary information for the assessment of the food additive.
Information on the characterisation of the different dimethyl polysiloxane fluids used in the
toxicological studies is provided in Appendix F.
3.5.1. Absorption, distribution, metabolism and excretion
Animal studies
Mice
Male Buckberg mice (12 animals/group, body weight 25 g) were given a single oral dose by gavage
of (1) sesame oil (control group), (2) silica (6 mg/kg bw – the amount of silica comparable to that in
‘DC Antifoam A’ and ‘DC Antifoam M’ (See Appendix F for information on the test material)), (3) ‘DC
Antifoam A’16 (0.5 ml/kg bw), (4) ‘DC A Emulsion’ (1.67 ml/kg bw which represents the same amount
of dimethyl polysiloxane as in group 3),(5) ‘DC Antifoam 351’ (0.5 mL/kg, a preparation similar to ‘DC
Antifoam M’17 with viscosity of 350 centistokes), (6) ‘DC Antifoam 352 Emulsion’ (1.67 mL/kg bw, a
30% emulsion made from ‘DC Antifoam 351’ and (7) ‘DC 360 Medical Grade 350 centistokes dimethyl
polysiloxane fluid’ (0.5 mL/kg bw, contains no free silica or free emulsifiers). At 4, 12 and 24 h after
treatment, four mice from each group were anaesthetised and urine and bile were taken for silicon
analysis by emission spectroscopy. There were no statistically significant differences in urinary or biliary
silicon concentrations, except for a statistically significant increased (p < 0.05, estimated by the
Panel to be approximately to 10-fold higher than the control) concentration in urine and bile from
group (3) and (4). The authors did not give the precise dose for these groups and did not quantify the
amount found in bile or urine. They stated that the increase in silicon only represented a negligible
amount of the dose administered for absorption from the gastrointestinal tract (Dow-Corning-
Corporation-Research-Department, 1974, Documentation provided to EFSA No. 8)).
Rats
The absorption of ‘14C-dimethyl polysiloxane’ (viscosity of 10 centistokes)18 was studied in Fischer
344 rats given a single oral dose of 1,000 mg/kg bw by gavage. The first part of the study consisted
of two exposure groups (4 males and 4 females, respectively; body weight of 146–203 g) and a
control group (2 rats/sex; not dosed) that were housed in metabolic cages for 96 h following
administration of the test substance for collection of excreta. In the second part of the study, whole
body autoradiography was used for the in vivo assessment of tissue distribution of radiolabelled
dimethyl polysiloxane (four males and four females, body weight of 146–203 g) at 12, 24, 48 and 96 h
following administration of the test substance. The majority of the radioactivity was rapidly excreted;
the recovery was 93.4% in female rats and 91.0%in male rats. The vast majority of excreted test
substance was recovered in the faeces (99.9% and 99.6% in females and males, respectively); all
radioactivity recovered in the faeces was attributed to unchanged dimethyl polysiloxane. Whole body
autoradiography showed that radioactivity was concentrated in the contents of the gastrointestinal
tract at 12, 24 and 48 h post-exposure. No radioactivity was present in tissues or organs at 96 h post-
exposure. The study authors concluded that following oral administration, the vast majority of 14C-
dimethyl polysiloxane was not absorbed but excreted unchanged in the faeces (Dow-Corning-
Corporation-Health-And-Environmental-Sciences, 2000(Documentation provided to EFSA No. 23)).
The absorption of ‘14C-dimethyl polysiloxane’ (viscosity of 350 centistokes) was studied in four male
and four female Fischer 344 rats, body weight 145–202 g, given a single oral dose of 1,000 mg/kg bw
by gavage. The control group consisted of two rats/sex. The animals were housed in metabolic cages
for 96 h following administration of the test substance. In the second part of the study, whole body
autoradiography of rats was used for assessing the tissue distribution of radiolabelled dimethyl
polysiloxane (four males and four females, body weight of 145–202 g) at 12, 24, 48 and 96 h
following administration of the test substance. In female rats 93.6% and in male rats 97.4% of the
radioactivity was recovered. Less than 0.1% was excreted by other ways than the faeces (99.98% of
16 DC Antifoam A is a mixture of 93% polydimethylsiloxane (CAS No 63148-62-9) and 7% silica treated with
polydimethylsiloxane (CAS No 67762-90-7) (Documentation provided to EFSA No 5).
17 DC Antifoam M is a mixture of 91% polydimethylsiloxane (CAS No 63148-62-9), 6% silica and 3% polydimethylsiloxane
hydroxy-terminated (CAS No 70131-67-8) (Documentation provided to EFSA No 5).
18 The Panel noted that this test material does not comply with EU specifications for E 900 regarding the viscosity.
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the total recovered dose in both males and females were found in the faeces). All radioactivity
recovered in the faeces was attributed to unchanged dimethyl polysiloxane. The whole-body
autoradiography showed that the radioactivity was concentrated in the contents of the gastrointestinal
tract at 12, 24 and 48 h post-exposure. No radioactivity was present in tissues and organs at 96 h
post-exposure. The study authors concluded that 14C-dimethyl polysiloxane was excreted unchanged in
the faeces following oral administration (Dow-Corning-Corporation-Health-And-Environmental-Sciences,
2001(Documentation provided to EFSA No 24)).
Lukasiak and co-workers examined the absorption and distribution of ‘OM-300’ (dimethyl
polysiloxane oil, viscosity of 300 centistokes) in male Wistar rats ((Lukasiak et al., 2001). The study
results were considered by the Panel to be unreliable as the method was not considered to be specific
for the analysis of the test material. Furthermore, few data are provided and those data that are
provided are reported as amounts (e.g. micrograms in blood) rather than as concentrations. The
Panel considered the study as not reliable.
Monkeys
Three Rhesus monkeys received a single oral dose (gavage) of 14C-labelled dimethyl polysiloxane
fluid (identical to ‘DC Antifoam A’ but silica-free, viscosity 397 centistokes) at dose levels of 1.15, 13.7
or 18.0 mg/kg bw. Approximately 0.5–0.9% of the dose was recovered in the expired air; the
pulmonary half-life was 4.6 h. Less than 0.1% of the dose was lost as volatiles from the urine, flatus
and faeces. Approximately 2.1–2.5% of the dose was recovered in the urine (half-life of 24 h),
0.1–0.3% in the bile (in the first 24 h) and 80–92% in the faeces (over 92 h). The peak blood levels
were below 1 lg/mL (detection limit) (Dow-Corning-Corporation-Research-Department, 1974
Documentation provided to EFSA No. 8)).
One Rhesus monkey received a single oral dose (gavage) of 14C-labelled dimethyl polysiloxane
(identical to ‘DC Antifoam M’ but silica-free, viscosity 932 centistokes) at a dose level of 21.8 and
another monkey at a dose level of 41.8 mg/kg bw of 14C-labelled dimethyl polysiloxane identical to DC
360 Medical Grade (335 cs). After 72 hours, 0.02 and 0.01% of the radioactivity were recovered in the
expired air, 0.02 and < 0.001% in the urine and 97 and 93% of the respective monkeys in the faeces.
Less than 0.01% of the low dose was found in the sum of around 40 different tissues examined
72 hours after dosing. Analysis of faeces from the high dose animal revealed that the parent
compound was excreted unchanged (Dow-Corning-Corporation-Research-Department, 1974
Documentation provided to EFSA No. 8)).
Human studies
Four men and two women received a single oral dose of ‘DC Antifoam A’19 and ‘DC Antifoam M’20
(100 mg/kg bw in sesame oil). In addition, three men and two women received a single oral dose of
‘DC A Emulsion’ and ‘DC M Emulsion’ (100 mg/kg bw, containing 30% of ‘DC Antifoam A’ and ‘DC
Antifoam M’, respectively). Total and organosoluble (methyl ethyl ketone-soluble) urinary silicon output,
as well as organosoluble (toluene-soluble) silicon output in expired air were measured. Administration
of ‘DC Antifoam M’ and ‘DC M Emulsion’ did not result in an increase of silicon in urine or in expired air,
whereas administration of ‘DC Antifoam A’ and ‘DC A Emulsion’ resulted in an increase in the urinary
excretion of silicon (average: 1.8 and 3.3 % for ‘DC Antifoam A’ and ‘DC A Emulsion’, respectively, over
6 days; half-life of 24 h for both test substances). At least 0.5 % of the dose was recovered in expired
air (half-life of 8 h); however, the exhaled material consisted principally of low molecular weight
cyclosiloxanes (octamethylcyclotetrasiloxane and decamethylcyclotetrasiloxane) which should not be
present in the food additive (Dow-Corning-Corporation-Research-Department, 1974 Documentation
provided to EFSA No. 8)).
Overall, dimethyl polysiloxane (various compositions and different viscosities – 10, 350 and 1,000
centistokes) is only absorbed to a very limited extent from the gastrointestinal tract following oral
administration to mice, rats, monkeys and humans. The vast majority (more than 99.9%) of the orally
administered dimethyl polysiloxane is excreted unchanged in the faeces. When comparing the two rat
studies (same strain of rats, F344), applying a pure dimethyl polysiloxane fluid with two different
viscosities (10 and 350 centistokes) resulted in no differences in absorption and excretion.
From the data available in humans, the Panel noted that the low molecular weight cyclosiloxanes
present in the test material (DC antifoam A) are absorbed from the GI tract. For this reason, the
19 Antifoam A contains 9.75% of cyclosiloxanes.
20 Antifoam M contains < 0.02% of cyclosiloxanes.
Re-evaluation of dimethyl polysiloxane (E 900)
www.efsa.europa.eu/efsajournal 21 EFSA Journal 2020;18(5):6107
Panel reiterates the recommendation for an amendment of the EU specifications in order to ensure the
absence of cyclosiloxanes in the food additive E 900.
3.5.2. Acute toxicity
‘DC 200 fluids’ (viscosity 350 centistokes (See Appendix F for information on the test material)) was
reported to be of low acute oral toxicity in rats (Rowe et al., 1948).
3.5.3. Short-term and subchronic toxicity
Mice
In a 90-day study in compliance with GLP, CD-1 mice (15 animals/sex per group, 7 weeks old) were
administered dimethyl polysiloxane fluid (viscosity of 3518 centistokes) at 0, 5 and 10 % in the diet
(equivalent to 0, 10,000 and 20,000 mg/kg bw per day of dimethyl polysiloxane) (Dow-Corning-
Corporation-Toxicology-Department, 1989a (Documentation provided to EFSA No. 14)). Animals were
observed daily clinical signs of toxicity, appearance, behavioural changes and mortality. The stool was
examined visually and the perianal region was examined for evidence of anal leakage of the fluid. Body
weights and food consumption were recorded weekly. At termination, major organs were collected,
weighed and examined for histopathological changes. Slight to moderate anal leakage of fluid was
observed in the 10 % group and almost all animals showed slight to moderate oily fur conditions
throughout the entire study period. Food consumption was significantly increased in both treatment
groups. No other significant findings were noted.
CD-1 mice (six animals/sex per group) were given 1, 5 or 10 % dimethyl polysiloxane fluid
(viscosity of 3518 or 1,000 centistokes) in food for 28 days (equivalent to 0, 2,000, 10,000 and
20,000 mg/kg bw per day of dimethyl polysiloxane). Slight anal leakage was noted following
administration of 5 % of the 35 centistoke dimethyl polysiloxane, slight to severe anal leakage
following administration of 10 % of the 35 centistoke dimethyl polysiloxane and normal to moderate
following administration of 10% of the 1,000 centistoke dimethyl polysiloxane. Statistically significant
increased food consumption was observed at the two highest dose levels. No other significant findings
were reported (United States Environmental Protection Agency, 1994c, as referred to by JECFA
(2009)).
Rats
Male Wistar rats (five animals/group) were administered 0 or 5% ‘OM-300’ (dimethyl polysiloxane
oil, viscosity of 300 centistokes (See Appendix F for information on the test material)) in the diet for
12 days (Lukasiak et al., 2001). After study termination, the brain, kidney, liver, spleen, cardiac muscle,
wall of the small intestine, suprarenal gland, pancreas and lung were examined histologically. No
histological changes and no other signs of toxicity were reported.
In a 28-day study performed in compliance with GLP and in accordance with OECD Guideline No
407 at that time (WIL-Research-Laboratories-Inc., 1995d, Documentation provided to EFSA No 42)),
Fischer 344 rats (10 animals/sex/group) were given 0, 10,000, 25,000, 50,000 and 100,000 mg/kg ‘DC
200 fluid’ (viscosity of 1018 centistokes (See Appendix F for information on the test material)) in the
diet (equal to 0, 978/1,043, 2,545/2,706, 5,244/5,623 and 11,228/12,058 mg/kg bw per day in males/
females, respectively). Clinical signs consisted of urogenital matting (yellow, clear, wet or dry) of the
fur at 50,000 mg/kg (in one-half of the animals) and in the fur as well as many other parts of the
body at 100,000 mg/kg in all animals. Corneal opacities (identified as corneal crystals) were observed
in almost all rats, with the highest incidences in the three highest dose groups, lowest in the control
group and intermediate in the lowest dose group. At the microscopic examination hyperplasia,
haemorrhage (only in the high-dose group), granulomatous inflammation and suppurative
inflammation of the corneal stroma were each observed at an incidence of 15–50 % at the two
highest dose levels. Moreover, hyperplasia of the corneal epithelium was observed in 30 % of males
and females at 50,000 mg/kg. As the ocular effects were only observed on the cornea, the study
report authors suggested that the matting of the fur and the corneal effects were possibly a result of
direct contact with the test substance in the feed, or with the test substance and/or a metabolite
excreted in the faeces. The Panel agreed with this. Mean food consumption was increased in the
50,000 and 100,000 mg/kg groups in both males and females. Mean triglycerides, and low density and
very low density lipoprotein cholesterol levels were significantly decreased in males at 25,000 and
50,000 mg/kg and in both sexes at 100,000 mg/kg. Other significant changes in serum biochemistry
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included increased blood urea nitrogen values in the male 10,000 mg/kg group, decreased glucose in
the male 25,000 mg/kg group and a decreased albumin/globulin ratio in the females 100,000 mg/kg
group. Significant organ weight changes included increased mean relative kidney weights in the male
at 50,000 and 100,000 mg/kg and decreased relative brain weights in the females at 25,000 and
50,000 mg/kg groups.
Another 28-day study performed in compliance with GLP and in accordance with OECD Guideline No
407 at that time was conducted in rats with a ‘DC 200 fluid’ (viscosity 350 centistokes (See Appendix F
for information on the test material)) (WIL-Research-Laboratories-Inc., 1995c, Documentation provided
to EFSA No 41)). Fischer 344 rats (10 animals/sex per group) were given 0, 10,000, 25,000, 50,000 and
100,000 mg/kg in the diet (equal to 0, 950/1,013, 2,428/2,562, 4986/5,286 and 10,615/11,325 mg/kg
bw per day in males/females, respectively). Clinical signs consisted of an increased incidence of matting
of the fur at 100,000 mg/kg. Corneal opacities (identified as corneal crystals) were observed in all
treated rats and in 18/20 control group rats, and keratitis with corneal vascularisation was present in 0,
3, 3, 3 and 14 rats in the control, 10,000, 25,000, 50000 and 100,000 mg/kg groups, respectively. At
the microscopic examination, hyperplasia and granulomatous inflammation of the corneal stroma were
present in all treated groups in a dose-related manner (incidence of stromal hyperplasia: 5, 15, 25 and
80%; granulomatous inflammation: 5, 15, 15 and 65% at the 10,000, 25,000, 50,000 and 100,000 mg/
kg groups, respectively); these lesions were not observed in the control group. Mineralisation of the
cornea sub-epithelium was observed in all groups including the control group (incidences from 50 to
95%) but was more severe in treated rats compared to control rats. As the ocular effects were only
observed on the cornea, the study report authors suggested that the matting of the fur and the corneal
effects were possibly a result of direct contact with the test substance in the feed, or with the test
substance and/or a metabolite excreted in the faeces. Mean food consumption was increased in the
male 25,000 and in both sexes at 50,000 and 100,000 mg/kg diet groups.
Sprague Dawley rats (10 animals/sex per treatment group, 20 animals/sex in the control group), were
given 1% in the diet ‘DC 200 fluid’ at different viscosities (5018, 350, 1,000, 10,000 and 60 000
centistokes (See Appendix F for information on the test materials)) (equal to 183/180, 192/180, 190/182,
190/175 and 180/177 mg/rat per day in males/females, respectively, of dimethyl polysiloxane) in the diet
for 90 days (MacDonald et al., 1960). Food consumption was recorded for each group of five animals.
Individual body weights were recorded at the start of the study and at day 45 and 90. Haematological
examinations were performed on half of the males and half of the females in each dosage group at the
start and at day 45 and 90. At day 90, all animals were sacrificed and examined for gross pathological
changes, organ weights were determined and histopathological examination was conducted on tissues.
No adverse effects were noted.
A 90-day study performed in compliance with GLP and in accordance with OECD Guideline No 408
at that time was conducted in rats with three different ‘DC 6370 fluids’ (dimethyl polysiloxane with
viscosity of 3518, 350 and 1,000 centistokes (See Appendix F for information on the test materials))
(Dow-Corning-Corporation-Toxicology-Department, 1989b (Documentation provided to EFSA No. 15)).
Sprague Dawley rats (20 animals/sex per group) were administered 0 (two control groups), 1, 5 and
10% in the diet (equivalent to 0, 900, 4,500 and 9,000 mg/kg bw per day of dimethyl polysiloxane).
Animals were observed daily for clinical signs of toxicity, appearance, behavioural changes and
mortality. The stool was examined visually and the perianal region was examined for evidence of anal
leakage of the fluid. Body weights and food consumption were recorded weekly. Ophthalmological
examination was performed prior to initiation and prior to termination of the study. At termination,
blood and urine samples were collected for haematology and clinical chemistry and urinalysis, and
major organs were collected, weighed and examined for histopathological changes. Slight to marked
anal leakage of fluid was observed at 10% for all viscosities; the amount of anal leakage decreased
with increasing viscosity. Slight anal leakage was also observed in some rats given diets with 5% of
low viscosity fluid (35 centistokes). Few statistically significant increases in body weight were observed
in the treated groups, but most of the body weight data were comparable between treated and
control rats. Significantly higher food consumption was observed in the 5 and 10 % groups, especially
in the males, of all viscosity fluids. The eye examination revealed corneal opacities and
neovascularisation in treated rats and the microscopic examination of the eyes showed minimal to mild
chronic inflammation of the cornea in treated animals of both sexes in a non-dose-related manner.
Mineralisation of the cornea was also noted in some animals. According to the authors of the study
report, the corneal effects may have been due to direct ocular irritation from the test substances in
the feed. Three lymphomas were recorded in treated males with two lymphatic lymphomas in male
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rats given 10 % of 1,000 centistokes fluid and one undifferentiated lymphoma in a male given 1 % of
35 centistokes fluid.
An additional dietary 90-day study was performed in male rats in compliance with GLP (100
animals/group) to either confirm or disregard whether the lymphomas observed in the experiment
described above were treatment-related (Dow-Corning-Corporation, 1989b (Documentation provided
to EFSA No. 15)). Sprague Dawley rats were assigned to each of two control groups and to each of
three test groups and given 10% of ‘DC 6370 fluids’ (viscosities of 3519, 350 and 1,000 centistokes
(See Appendix F for information on the test material)) (equivalent to 9,000 mg/kg bw per day of
dimethyl polysiloxane). The animals were examined as described in the previous study. All treatment
groups displayed higher mean food consumption. No other significant findings were noted. The data
from the study did not confirm the previous observation of an increased number of lymphoma in
treated animals (Dow-Corning-Corporation-Toxicology-Department, 1989b (Documentation provided to
EFSA No. 15)).
In a 90-day study performed in compliance with GLP and in accordance with OECD Guideline No
408 at that time (WIL-Research-Laboratories-Inc., 1995a, (Documentation provided to EFSA No 39)).
Fischer 344 rats (15 animals/sex per group) were given ‘DC 200 fluid’ (viscosity: 1018 centistokes (See
Appendix F for information on the test material)) in the diet at 0, 5,000, 10,000, 25,000 and
50,000 mg/kg (equal to 0, 351/395, 718/792, 1,780/2,025 and 3,773/4,348 in males/females,
respectively). Clinical signs consisted of matting at the base of the tail and the anogenital region at
50,000 mg/kg (all males and most females), as well as matting of other parts of the body at a higher
incidence at 50,000 mg/kg males and females. Corneal opacities were observed in almost all rats with
dose–response relationship in the severity. At the microscopic examination, suppurative inflammation
of the corneal stroma (0/15, 1/15, 0/15, 6/15 and 8/15 for males; 0/15, 0/15, 0/15, 0/15 and 4/15 for
females in control, 5,000, 10,000, 25,000 and 50,000 mg/kg groups, respectively) and
neovascularisation of the corneal stroma were observed in one male at 25,000 mg/kg and in two
females at 50,000 mg/kg. The authors of the study report suggested that the matting of the fur and
the corneal effects were possibly a result of direct contact with the test substance in the feed, or with
the test substance and/or a metabolite excreted in the faeces. Incidental increase in mean food
consumption was observed in the 10,000, 25,000 and 50,000 mg/kg groups in male and females.
Mean total cholesterol, high density lipoprotein cholesterol and phospholipid levels were significantly
decreased in all males treated groups except for the cholesterol and phospholipid means at 5,000 mg/kg.
Other significant changes in serum biochemistry included a lower mean creatinine value in males at
25,000 mg/kg, an increase in mean total bilirubin in females at 5,000 mg/kg, an increase in the mean
total protein value in females at 10,000 mg/kg and an increase in the mean albumin value in females at
25,000 mg/kg. Regarding urinalysis, a decreased pH was observed in males at 50,000 mg/kg.
Another 90-day study performed in compliance with GLP and in accordance with OECD Guideline
No 408 at that time was conducted in rats with a ‘DC 200 fluid’ (350 centistokes (See Appendix F for
information on the test material)) (WIL-Research-Laboratories-Inc., 1995b, Documentation provided to
EFSA No 40). Fischer 344 (15 animals/group) were given 0, 5,000, 10,000, 25,000 and 50,000 mg/kg
in the diet (equal to 0, 312/352, 618/716, 1,590/1,790 and 3,347/3,824 in males/females, respectively.
To further investigate the potential of the test substance to induce corneal opacities during dietary and
gavage routes of administration, the test substance was also administered daily by gavage to two
groups rats (15 animals/sex per group) at dose levels of 0, 500 or 2,500 mg/kg bw per day for
90 days. Clinical signs consisted of matting at the base of the tail occasionally in the male 2 500 mg/
kg bw per day gavage group and infrequently in females 2,500 mg/kg bw per day gavage group
during weeks 8–13. Matting was not reported in animals given the test substance in the diet at the
two highest dose levels (from approximately 1 600 to 3 800 mg/kg bw per day). Corneal opacities
(identified as corneal crystals) were observed in all animals in all groups (control and treated). After
1 week of treatment, corneal opacities occurred generally more frequently in the dietary groups when
compared to the diet control group, gavage control and gavage-treated groups. After 2 weeks of
treatment, most of the treated animals (both dietary and gavage) had corneal opacities while most of
the males and half of the females in the diet and gavage control groups had corneal opacities. All
animals in all groups had corneal opacities after 3 weeks of treatment. The severity of the corneal
opacities was increased in a dose-related manner in all treatment groups when compared to the
control groups. At the microscopic examination, suppurative inflammation of the corneal epithelium
occurred at a dose-related increased incidence in all treatment groups when compared to the control
groups. The study report authors suggested that the matting of the fur and the corneal effects
possibly was a result of direct contact with the test substance in the feed, or with the test substance
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and/or a metabolite excreted in the faeces. Mean food consumption was increased at 20,000 mg/kg in
females and at 50,000 mg/kg in both genders.
Rabbits
Adult New Zealand albino rabbits (three animals/sex per treatment group, six animals/sex in the
control group) were given 0 or 1% in the diet of either ‘DC 360 fluid’ (viscosity: 5018 or 350
centistokes (See Appendix F for information on the test material)) or ‘DC Antifoam A’ ((See Appendix F
for information on the test material)) for 8 months (Carson et al., 1966). Animals were observed daily
and body weights were recorded weekly. Haematological and urinary examinations were performed at
the start of the study and after 4 and 8 months. Additionally, at 8 months, blood urea nitrogen, serum
cholesterol, alkaline phosphatase and glutamic pyruvic transaminase were determined. At the end of
the study, organs were weighed, and macro- and microscopic examination was performed. No
significant differences between treated animals and controls were reported.
Dogs
Dogs (two animals/group, body weight and age not specified but it is mentioned that the dogs
were nearly full grown at the start of the study) were given for 3 months in the diet ‘DC Antifoam A’
((See Appendix F for information on the test material)) at 0, 300, 1,000 and 3,000 mg/kg bw per day,
5 days per week (Child et al., 1951). Due to poor reporting and limitations of the study (e.g. study
design, dog general health, changes in the diet), this study was not considered for the hazard
identification.
A 13-week oral toxicity study was conducted in dog with DC Medical Antifoam 351 (See Appendix F
for information on the test material) (Atlas Chemical Industries, 1969 (Documentation provided to
EFSA No. 2)). Dogs (three animals/sex per group) received 120, 380 or 1,200 mg/kg bw per day. Body
weight, water and food consumption were recorded. Urine output was measured once a week for a
24- hour period. At week 2 and 4, values for haematology and clinical chemistry were determined. At
termination, blood and urine samples were collected for haematology and clinical chemistry and
urinalysis, and major organs were collected, weighed and examined for histopathological changes. Soft
stools were reported to occur in all treatment groups, including control, with the presence of mucus
and, in some instances, blood. Mean weight of thyroid, heart and pituitary gland was increased in the
high-dose group in males. Mean weight of spleen was increased at 1,200 and 380 mg/kg bw per day
in male and mean weight of gonads was increased in all dose groups compared to the control group in
males. No gross or histological lesions related to administration of DC Medical Antifoam 351 were
observed. In females, increase in mean gonads weight at 120 mg/kg bw per day was observed.
A 120-day oral toxicity study was conducted in dogs with dimethyl polysiloxane (91%) and
‘siloxanes and silicones, di-Me, hydroxy-terminated 2.9% in MS antifoam M’ (See Appendix F for
information on the test material) (University of Birmingham, 1968 (Documentation provided to EFSA
No 38)). Dogs (four animals/sex per group) received 300 mg/kg bw per day for 120 days followed by
5 days of recovery period. Body weight was recorded weekly. At termination, blood and urine samples
were collected for haematology and clinical chemistry and urinalysis, and major organs were collected,
weighed and examined for histopathological changes. A non-statistically significant decrease in body
weight has been observed in the treated animals in the first 3 weeks of treatment followed by a
recovery in the following weeks. No changes in haematological parameter were observed. No
significant findings were noted at macroscopic and microscopic examination except for one dog in
which a healed gastric ulcer was observed.
Overall, dimethyl polysiloxane with different viscosities have been administered in the diet in mice
(28 and 90 days) and in rats in three 28-day studies and in five 90-day studies, whit most of the
studies performed with GLP standards. Most of the studies in both mice and rats showed anal leakage
and matting in the urogenital area, and an increase in food consumption. Corneal opacities and other
effects on cornea such as inflammation and vascularisation have been observed in some rat studies at
doses ranging from 900 to 12,000 mg/kg bw per days. These effects were suggested by the authors
to be caused by direct contact with the test substance in the feed, or with the test substance and/or a
metabolite excreted in the faeces. The Panel agrees with the suggestion of the authors. In some
studies, corneal effects were also observed in the control. This was most likely due to contamination
from cages with exposed animals. The Panel noted that in old studies in rabbits and dogs described
above, no corneal effects were observed.
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3.5.4. Genotoxicity
Available genotoxicity studies including those mentioned in a report of the Cosmetic Ingredient
Review (CIR) Expert Panel (CIR, 2003) and for which the unpublished study reports were available to
the Panel are summarised in Appendix G.
Dimethyl polysiloxane (as well as some structurally related substances) did not induce gene
mutations in several bacterial reverse mutation tests in the presence and absence of metabolic
activation when tested at concentrations up to 10,000 lg/plate. ‘Dimethyl silicones and siloxanes’ (a
mixture that contains a substance with the CAS No 63148-62-9) did not induce mutations in CHO cells
in an in vitro mammalian cell gene mutation test using the Hprt gene nor did it induce chromosomal
aberrations in CHO cells in vitro when tested in the presence and absence of metabolic activation at
concentrations up to 10,000 lg/mL, respectively. There is, however, some uncertainty about the actual
concentrations of ‘dimethyl silicones and siloxanes’ in the cell cultures of these assays because it was
stated in some study reports that, due to the low solubility of ‘dimethyl silicones and siloxanes’, an
extract was prepared (with cell culture medium in some studies or ethanol in other studies), but the
concentrations of ‘dimethyl silicones and siloxanes’ in these extracts were not reported. In the study
report of one in vitro mammalian cell gene mutation test, it was stated that ethanol was used as
solvent; however, in the light of the information given in other study reports, the actual concentration
of ‘dimethyl silicones and siloxanes’ seems to be uncertain also in this study.
In two in vivo micronucleus assays, ‘dimethyl silicones and siloxanes’ did not induce increased
frequencies of micronuclei in peripheral blood of mice after single i.p. administration. Whereas the
relevance of one study result is low because the concentration of ‘dimethyl silicones and siloxanes’ in
the extract used for dosing of animals was not reported, the result of the other study can be
considered relevant because the concentrations of ‘cyclics’ and ‘linears’ of ‘Dimethyl silicones and
siloxanes’ in the ethanol extract used for dosing of animals were analysed by gas chromatography and
the doses expressed as ‘cyclics’ and ‘linears’ were calculated.
In addition, a dominant lethal assay has been performed in mice (strain, number of animals/group,
age and body weight were not specified). ‘DC 700 vapour booster pump fluid’ (viscosity of 718
centistokes (See Appendix F for information on the test material)) was given as a single intraperitoneal
injection at 5,000 or 10,000 mg/kg bw. No mutagenic potential of the test compound was reported
(Kennedy et al., 1976). The Panel noted that the study was conducted before OECD TG 478 was
established and that it was only poorly reported.
No alerts for genotoxicity have been identified using the OECD QSAR toolbox, using as input in one
case the chemical structure of the monomer and in a second case the CAS No 63148-62-9 of the
polymer.
Overall, based on the available information, the Panel concluded that there is no concern with
respect to genotoxicity of dimethyl polysiloxane (E 900).
3.5.5. Chronic toxicity and carcinogenicity
Mice
Mice (of an outbred strain form the Laboratory Animals Centre Carshalton Surrey, 40–50/sex per
group) were given a ‘silicone antifoam agent’ (containing 94% dimethyl polysiloxane silicone oil and
6% finely divided silicon dioxide, according to the authors the polymers in the silicone oil resembled
those of ‘DC Antifoam A’ except that the low molecular weight compounds had been excluded in the
oil) in the diet at levels of 0, 0.25 and 2.5 % (equal to 580 and 5,800 mg dimethyl polysiloxane
silicone/kg) for 76 weeks (Cutler et al., 1974). Surviving animals were sacrificed at week 80 and a
microscopical examination was performed on all tissues. Five animals of each sex from the 2.5% group
were at week 75 transferred to the control diet for 8 days before they were sacrificed after which the
whole body was analysed for silicone content. Silicone was not detected in the bodies of the high-dose
mice. The incidence of superficial ulcers of the stomach was statistically increased in males of the mid-
dose group, but not in males of the high-dose group. The incidence of simple cysts in the ovaries was
high in the mid-dose group females, but not in the high-dose group. Other non-neoplastic
histopathological changes were scattered among the groups or occurred at a low incidence in one
group. The authors considered the non-neoplastic histopathological lesions unrelated to treatment. The
Panel agreed with this conclusion. There was no increase in the incidence of malignant or benign
tumours in the group receiving dimethyl polysiloxane oil in their diet.
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Rats
In a 1-year study, albino FDRL rats (10 animals/sex in the control group and 5 animals/sex per
treatment group,) were given 0 or 1 % in the diet of either ‘DC 360 fluid’ (equivalent to 500 mg/kg bw
per day of dimethyl polysiloxan) (viscosity of 5018 or 350 centistokes (See Appendix F for information
on the test material)) or ‘DC Antifoam A’ (equivalent to about 290 mg/kg bw per day of dimethyl
polysiloxane) (Carson et al., 1966). Body weight and food consumption were recorded weekly. After 3,
6 and 12 months, haematological and urinary examinations were performed. At termination, major
organs were collected, weighed and examined for histopathological changes. Males of the Antifoam A
group showed significantly (p < 0.05) greater growth as compared to control animals. No other
significant differences were reported.
In a 2-year study Wistar rats (25 animals/sex per group) were given 0 or 0.3% ‘DC Antifoam A’
(See Appendix F for information on the test material) in the diet (equivalent to 139 mg/kg bw per day
of dimethyl polysiloxane and assuming that the content of dimethyl polysiloxane in ‘DC Antifoam A’ is
about 93%) (Rowe et al., 1950). Haematological examinations were performed periodically in a group
of 10 female rats (treated and control) during the course of the study. At termination, blood samples
were collected for haematology and clinical chemistry, and major organs were collected, weighed and
examined for histopathological changes. The average final body weight of treated male rats was
increased compared to that of the controls. No other effects were reported.
A combined 24 months chronic oral toxicity and carcinogenicity study in compliance with GLP and in
accordance with OECD Guideline 453 at that time was conducted in rats (WIL-Research-Laboratories-
Inc., 2003 (Documentation provided to EFSA No 43)). Fischer 344 (90 animals/sex per group) were
given 0, 100, 300 and 1,000 mg/kg bw per day ‘DC 200 fluid’ (viscosity of 10 centistokes18 (See
Appendix F for information on the test material)) in the diet for 12 and 24 months. Clinical signs
consisted of slightly increased incidences of wet or dried yellow material on various body parts
(primarily the urogenital and anogenital areas) in males at all dose levels in females at the two highest
dose levels. The incidence of corneal opacities was slightly increased in high-dose males and in
females at the two highest dose levels and was generally noted during the first year of the study and
throughout the second year for both the carcinogenicity and chronic recovery groups. At the
microscopic examination a higher, statistically significant (p < 0.05 or p < 0.01) incidence of minimal to
mild keratitis (characterised by small numbers of inflammatory cells, usually mononuclear cells admixed
with fewer numbers of neutrophils) within the corneal stroma was observed at all dose levels in the
carcinogenicity group. A higher incidence of bilateral keratitis was also observed at all dose levels in
the carcinogenicity group in comparison to the control group in which the lesion usually was unilateral.
Keratitis was observed at similar incidences and severities in treated and control females in the chronic
recovery groups and at slightly higher incidences in the treated males in the chronic recovery group.
The study report authors suggested the corneal effects most likely to be the results of local irritation
and the matting of the fur to be most likely related to the test substance passing through the
gastrointestinal tract. Inflammation of the nasolacrimal duct in nasal level III (very close to the ostium
in the conjunctiva) was observed in some animals from all groups, but with a slightly higher incidence
(p < 0.05) and severity in the male high-dose carcinogenicity group. The authors of the study report
considered the increased inflammation of the nasolacrimal duct at the nasal level III to be secondary
to the draining of the test substance from the eye into the duct and there causing local irritation. No
other significant non-neoplastic findings were noted. Regarding neoplastic changes, a statistically
significant increase (p < 0.05) in the incidence of pancreatic islet cell adenomas was observed in the
male high-dose carcinogenicity group. Islet cell adenomas are common age-related lesions found in
rats, mice, dogs, ferrets and cattle (Rosol et al., 2013). The incidences may vary among studies and
can reach 15–25% as seen in the male controls and high-dose males of the chronic recovery group of
the present study, respectively. Moreover, as indicated by the authors of the study, the incidences of
the islet cell adenomas in the male groups of the present study were within the historical control
ranges for Fischer 344 rats in the NTP historical database.
Therefore, the Panel agreed with the authors that the increased incidence of islet cell adenomas in
males of the 1,000 mg/kg per day group was not related to treatment with the test article. No other
significant neoplastic findings were noted.
In a 26-month carcinogenicity study performed in compliance with GLP and accordance with the
‘Guidelines for Designation of Food Additives and for Revision of Standards for Use of Food Additives’
of the Japanese Ministry of Health and Welfare (Kawabe et al., 2005), Fischer 344 rats (50 animals/sex
per group) were given ‘KS66’ (See Appendix F for information on the test material; viscosity of
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approximately 310 centistokes, test material contains 8% of silica) in the diet at 0, 1.25 and 5% (equal
to 0, 530/445 and 2,234/1,894 mg/kg bw per day in males/females, respectively) for 104 weeks.
Animals were examined twice daily for general health and signs of toxicity. At termination, blood
samples were collected for haematology, and major organs were collected, weighed and examined for
gross pathological and histopathological changes, including eyes. No treatment-related changes were
reported for clinical signs, survival rates, food consumption and haematology data. There was a
significant increase in final body weights in females at both doses along with significant decreases in
relative organ weights in kidney, brain and heart and at the lower dose for relative liver and adrenal
weights. A decrease in relative liver weight was also observed in the high-dose males. The
Panel considered the decreases of relative organ weights to be of no toxicological concern. No
toxicologically relevant treatment-related effects or increased incidences of any non-neoplastic or
neoplastic lesions were reported. The Panel identified the highest dose tested, 1,894 and 2,234 mg/kg
bw per day for females and males, respectively, as NOAELs. Considering that the test material
contained 92% of dimethyl polysiloxane, these NOAELs correspond to 1,742 and 2,055 mg dimethyl
polysiloxane/kg bw per day.
Oral administration of dimethyl polysiloxane in the diet to rats for up to 2 years resulted in matting
of the fur (predominantly in the urogenital and/or anogenital areas), corneal effects/lesions
inflammation of the nasolacrimal duct (WIL-Research-Laboratories-Inc., 2003) (Documentation
provided to EFSA No 43), whereas no treatment-related effects were reported in another 2-year
dietary study in rats (Kawabe et al., 2005) or in older studies performed in rats (Carson et al., 1966),
(Rowe et al., 1950), and in mice (Cutler et al., 1974).
Overall, the Panel considered that dimethyl polysiloxane was not carcinogenic and did not cause
any systemic toxicity. The matting of the fur, corneal effects and inflammation of the nasolacrimal duct
was considered to be caused by direct contact with the test substance in the feed or with the test
substance excreted in the faeces.
3.5.6. Reproductive and developmental toxicity
Reproductive toxicity studies
A three-generation toxicity study was performed in Weanling rats (30 females and 10 males per
group; strain, body weight not specified) (Frazer, 1959 (Documentation provided to EFSA No. 29)).
Rats received 0, 0.01 or 0.1% ‘DC Antifoam A’ ((See Appendix F for information on the test material))
in the diet (equivalent to 0, 4.5 or 45 mg/kg bw per day of dimethyl polysiloxane). After 16 weeks, the
animals were mated (one male caged together with three females for 21 days). Ten males and 30
females were chosen randomly from the offspring in each group (generation I), fed the same diet as
their parents (generation 0), and mated after 15 weeks. Ten males and 30 females were chosen
randomly from the offspring in each group (generation I), were mated (as for generation 0) and 30
female and 10 male offspring were randomly selected (generation II). In generation 0, the body
weights were recorded weekly until study week 15; in generation I and II, body weights were
recorded weekly until the animals were 15 and 13 weeks old, respectively. The reproductive
performance was evaluated by considering a male as sterile if none of the females in the case
produced a litter and a female as sterile if no litter was produced after being caged with a fertile male
for 21 days. The number of litters born in each group and the number of pups in each litter was
recorded and litters containing more than eight pups were culled to that number; litters with a lower
number of pups were left unchanged. The survival rate at post-natal day 21 was also recorded.
Haematological examinations (total erythrocyte, lymphocyte, monocyte and granulocyte counts, and
haemoglobin) were performed after 25 weeks in generation I and after 20 weeks in generation II (five
animals of each sex from each group). Surviving animals were sacrificed after 2 years (generation 0),
28 weeks (generation I) and 23 weeks (generation II) and 3 females from each group of each
generation were chosen randomly for histological examination of main organs (no details). Organ
weights (heart, spleen, liver, kidneys, stomach, intestine, caecum, adrenals, ovaries and uterus) were
recorded for 10 females of each group in generation I and II, and testes weight were recorded for
males. Significant differences in body weight between control and treated groups were noted in
generation I and II without a consistent trend to decreased or increased weight between particular
groups; the study report authors concluded that the observed changes were not of toxicological
significance. Regarding reproductive performance, the survival rate of the generation 0 offspring was
slightly higher in the high dose group as compared to controls, but lower (p < 0.01) in the generation I
offspring; the study report authors considered these findings to be of doubtful significance in the
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absence of other signs of toxicity. No other significant differences were reported. The Panel noted that




In a prenatal developmental toxicity study, pregnant Wistar rat was daily exposed by gavage to 0,
380, 1,200 or 3,800 mg DC Antifoam A/kg bw per day (See Appendix F for information on the test
material) from gestation day (GD) 6 to 15 for 10 consecutive days (Atlas Chemical Industries, 1970
(Documentation provided to EFSA No. 3)). The authors noted that of the 240 females that were caged
to male rats only approximately 40% was mated. From these mated females, 25 per group were
assigned to the dose groups. In addition, in all those groups, only 67 females were pregnant at term,
altogether. The number of pregnant females at term was 13, 19, 18 or 17 for the control, low-, mid-
or high-dose group. On GD 20, a Caesarian section was performed. The number of corpora lutea,
implantation sites, early and late resorptions, live and dead fetuses and fetal weight were recorded.
One-third of the fetuses were used for visceral screening and the remaining two-third for skeletal
examination. The number of mated rats (sperm positive or vaginal plug) 24 in the control and 25 in
the group dosed with DC Antifoam A. No treatment-related developmental effects were observed. This
study cannot be used for hazard assessment due to the aberrant fertility conditions of the animals and
the low number of pregnant females at Caesarian section.
In a prenatal developmental toxicity study, female rats (strain, number of animals/group, age and
body weight not specified) were given ‘DC 700 vapour booster pump fluid’ (viscosity of 718 centistokes
(See Appendix F for information on the test material))) by oral gavage at 0, 300 or 1,000 mg/kg bw
per day during GDs 6–15 (Kennedy et al., 1976). On 20 the females were sacrificed, fetuses were
taken by Caesarean section and uterus and ovaries were examined. The number of implantation sites,
and live and dead pups were counted, approximately one-third of the pups were examined grossly,
and the remaining pups were examined for skeletal abnormalities. No adverse effects were reported.
The reporting of the study was very limited.
Rabbits
In a prenatal developmental toxicity study, time-mated New Zealand white rabbits (n = 20–22 per
group) were fed 0, 0.5, 1.0 or 2.5% DC Antifoam A in the diet (equivalent to 0, 152, 303 or 756 mg
DC Antifoam A/kg bw per day) from GD 6 through the morning of GD 19 (Siddiqui et al. 1994; only
abstract available). No clinical signs, differences in body or liver weight were observed in the does. The
number of resorptions, and fetal weight were not affected. No treatment-related effects were observed
at fetal external, visceral or skeletal examination. The author concluded that not treatment-related
developmental effects were observed. The Panel noted that as only an abstract was available, this
study cannot be used for hazard assessment.
Overall, dimethyl polysiloxane was tested in a dietary three-generation toxicity study in rats (Frazer,
1959 (Documentation provided to EFSA No 29)). The Panel noted that the highest dose tested was
only 45 mg dimethyl polysiloxane/kg bw per day. No adverse effects were reported in a prenatal
developmental toxicity study in rats up to 1,000 mg/kg bw per day (Kennedy et al., 1976).
Furthermore, in a prenatal developmental study in rats, no treatment-related developmental effects up
to doses of 3,800 mg DC Antifoam A/kg bw per day by gavage were observed. Developmental effects
of DC Antifoam A in the diet up to 2% (equivalent to 756 mg/kg bw per day) was also studied in New
Zealand White rabbits and no treatment-related effects were observed. None of the studies could be
used for hazard assessment due to the different limitations mentioned above.
3.5.7. Other studies and case reports
Effects on eyes
Humans
In humans, dimethyl polysiloxane fluids of various viscosities (also called silicone oils) are used as
an intraocular tamponade during retinal detachment repairs. Retinal and corneal lesions (keratopathy
and degeneration of the corneal endothelium) have been reported as a complication of their use.
An examination by light microscopy of corneal tissue from two patients with corneal complications
after intraocular injection of silicone oil showed increased cellularity and irregularity of stromal collagen
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fibres, endothelial cell degeneration and loss of endothelial cells. This was accompanied by flattening
and thinning of the remaining cells and attenuation of cell borders as determined by electron
microscopy (Choi et al., 1993).
Ten patients who developed corneal complications (requiring keratoplasty) after silicone oil-induced
keratopathy showed, in some cases, corneal oedema, corneal hypaesthesia, endothelial opacification,
band keratopathy and peripheral corneal vascularisation. Histologically, retrocorneal membranes and
different degrees of stromal hypercellularity, superficial stroma calcification and vascularisation were
noted in these patients (Foulks et al., 1991).
The eight cases of oculopathy found in the Eudravigilance database were reported by the
pharmaceutical company responsible for the products which were named in conjunction with the
observed adverse event.
Eight cases of keratopathy were reported taken from a publication. In all the cases, silicone oil was
applied locally and a retained in the eye. In the cases, silicone oil-induced keratopathy has been
developed. From these reports in which silicone oil was causing the keratopathy it can be deduced
that the effect was clearly due to the local application and not due to systematic exposure.
Animals
Injection of dimethyl polysiloxane (identity not specified) in the anterior chamber of the eyes of
rabbits (14 animals) and cats (7 animals) induced a 40% reduction in retinal endothelial cell density in
the location of the silicone oil bubble. In rabbits, progressive corneal stromal thinning, with gradual
development of a retrocorneal membrane at the junction of endothelial contact with the silicone oil,
was observed. In cats, persistent stromal oedema, peripheral vascularisation, irregular plaques on the
endothelium, epithelial ulceration and corneal thinning occurred (Sternberg et al., 1985).
A second study in adult albino rabbits in which silicone oil (identity not specified) was injected into
the eyes following vitrectomy showed damage to the corneal endothelial layer, ranging from loose
intercellular connections to severe damage of the plasma membranes in degenerating the cells
(Versura et al., 2001).
In a study with anaesthetised pigmented rabbits, 0.7–1.0 mL of oxygenated generic dimethyl
polysiloxane (viscosity of 500, 1,000 and 12,500 centistokes) or medical-grade dimethyl polysiloxane 360
(viscosity of 1,000 centistokes (See Appendix F for information on the test material)) was placed in an
eye cup (formed by the lids and hanging sutures) for 3–6 h. The untreated eye served as control. Light
microscopic examination of the eyes immediately after treatment showed intracellular oedema of the
epithelium and some vacuolisation of the superficial cells. Increased epithelial and whole corneal
thickness was subsequently observed which persisted for several days in most cases. A marked
irregularity in the thickness of the epithelium and cornea was observed in most treated eyes by 3 days. At
3–7 days after treatment, the most common findings were irregular thickening of the epithelium and a
general disorganisation of the normal epithelial architecture. Transmission electron microscopic
examination at 5 days showed mild intracellular epithelial oedema, particularly in the basal cell layers and
in the middle layers of the cornea in rabbits exposed to medical-grade dimethyl polysiloxane. The generic
dimethyl polysiloxane of the lowest viscosities caused a more intense reaction (Refojo et al., 1985).
In an eye irritation study in New Zealand White rabbits (three males/group), 0.1 mL of ‘DC 200 fluid
(viscosity of 2,18 100, 500, 1,000 or 12,500 centistokes (See Appendix F for information on the test
material)) was instilled in the conjunctival sac of the right eye. The untreated left eye served as control.
Observations were made at 1, 6, 24, 48 and 72 h following treatment. All fluids caused mild transitory
conjunctival redness (grade 1) with higher viscosity grades giving more persistent redness (up to 2 days
after instillation). No effects on the cornea or iris were observed (Dow-Corning-Corporation-Health-And-
Environmental-Sciences-Toxicology-Department, 1982 (Documentation provided to EFSA No. 10)).
The Panel considered that dimethyl polysiloxane may damage the cornea in humans and animals
following intra-ocular treatment but noted that this is not relevant for its use as a food additive.
Other human data
Clinical studies
Several short-term studies (ranging from a single oral dose to up to four consecutive oral doses)
were performed to determine the suitability of dimethyl polysiloxane (dimethicone) as an agent to
reduce gastrointestinal gas and improve the quality of ultrasound investigations of the abdomen. The
studies recruited 20 patients (Gladisch et al., 1985) and 28 patients (Sommer et al. 1977). Jacyna
et al. (1984) also tested dimethyl polysiloxane when combined with antacids in 60 subjects. In an
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8-week study, Smart and Atkinson (1990) compared the efficacy of a dimethicon/antacid containing
preparation (n = 28) vs. an alginate/antacid containing preparation (n = 25) in patients with reflux
oesophagitis.
None of the studies indicated any adverse effects from the administration of dimethyl polysiloxane
or any of the dimethyl polysiloxane-containing preparations.
Spontaneous reporting of adverse reactions
From the Eudravigilance database,21 153 cases reports were identified using the search term
“dimethicone”; most of them reporting on non-serious effects.
However, cases of mesothelioma or others with lung malignancies were identified and were
considered by the Panel as serious22:
Mesothelioma
The Eudravigilance database contained 30 cases of mesothelioma. When assessing the available
information, in all cases it is said that they are observed after using Gold Bond which is a series of skin
care products containing dimethyl polysiloxane as indicated by the reporting pharmaceutical company
responsible for the products. The skin care products are available on the market as body powder and
body powder spray among other application forms. It is further said that 22 of the patients suffered
from an asbestos-induced disease or had asbestos exposure in their history.
From these reports, it can be deduced that mesothelioma was observed in patients who were
mostly exposed to asbestos in their history, besides eight patients. All patients had used a skin care
product available on the market as body powder and body powder spray and were exposed by the
inhalation route or transdermal route and not by the oral route. Hence, the observed events are not
relevant for the assessment of dimethyl polysiloxane as a food additive.
Lung cancer
The Eudravigilance database contained 26 cases of lung cancer. When assessing the available
information, in all cases it is said that they are observed after using Gold Bond which is a series of skin
care products containing dimethyl polysiloxane as indicated by the reporting pharmaceutical company
responsible for the products. The skin care products are available on the market as body powder and
body powder spray among other application forms. It is further said that 24 of the patients suffered
from an asbestos-induced disease or had asbestos exposure in their history.
From these reports, it can be deduced that the lung cancer was observed in patients who were
exposed to asbestos in their history, besides two patients. All patients had used a skin care product
available on the market as body powder and body powder spray and were exposed by the inhalation
route or transdermal route and not by the oral route. Hence, the observed events are not relevant for
the assessment of dimethyl polysiloxane as a food additive.
Overall, the Panel considered that the reported cases of mesothelioma or other lung cancers were
most likely almost exclusively associated with a pre-existing asbestos-induced disease and/or a history
of asbestos exposure. These cases were also associated with the use of a body powder and/or body
powder spray containing multiple components, in addition to dimethyl polysiloxane, via routes of
exposure (inhalation/transdermal) not relevant to dimethyl polysiloxane use as a food additive.
3.6. Discussion
Specifications for dimethyl polysiloxane (E 900) are defined in the Commission Regulation (EU) No
231/2012. Having evaluated information submitted by interested parties on dimethyl polysiloxane and
its manufacturing process, the Panel would recommend that specifications should be updated in order
to better describe the material used as a food additive and ensure its safety of use:
• Include the range of the weight average molecular weight (Mw) and number average
molecular weight (Mn) for dimethyl polysiloxane used as a food additive E 900.
• Include a maximum limit for cyclopolysiloxanes.
21 The pharmacovigilance database of the European Medicines Agency (EMA).
22 A serious adverse event is any event that is fatal or life-threatening permanently/significantly disabling (impairment, damage
or disruption in the patient’s body function/structure, physical activities or quality of life) requires or prolongs hospitalisation
causes a congenital anomaly requires intervention to prevent permanent impairment or damage. Available online: https://
apps.who.int/medicinedocs/en/d/Jh2992e/2.html
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• Include a maximum limit for copper since copper-based catalysts are used in the
manufacturing process.
• Setting lower limits for toxic elements (arsenic, lead, mercury).
• Revising the name of the substance to ‘poly(dimethylsiloxane).’
The Panel noted that the test materials in some toxicological studies were preparations of dimethyl
polysiloxane containing silica. The Panel was of opinion that, provided that the test item was
considered relevant, this presence of silica in the test material did not affect the outcome of these
toxicological studies.
Dimethyl polysiloxane (various compositions and different viscosities – 10, 350 and 1,000
centistokes) was only absorbed to a very limited extent from the gastrointestinal tract following oral
administration to mice, rats, monkeys and humans. The vast majority (more than 99.9%) of the orally
administered dimethyl polysiloxane was excreted unchanged in the faeces.
The acute toxicity of dimethyl polysiloxane is low. There is no concern with respect to genotoxicity
of dimethyl polysiloxane (E 900).
In short-term and subchronic toxicity studies in mice, rats and dogs, anal leakage and matting in
the urogenital area were reported. Corneal opacities and other effects on cornea such as inflammation
and vascularisation have been observed in some rat studies at doses ranging from 900 to 100,000 mg/
kg bw per day. Similarly, in chronic toxicity and carcinogenicity studies in mice and rats matting of the
fur (predominantly in the urogenital and/or anogenital areas) along with effects on the cornea and
inflammation of the nasolacrimal duct were observed.
The Panel agrees with the suggestion of the authors that these effects were caused by direct
contact with the test substance in the feed, or with the test substance in the faeces and not due to
systemic exposure. A local effect is supported by the following:
– The vast majority of dimethyl polysiloxane is not absorbed and thus excreted via faeces,
consequently contaminating beddings and cages.
– Additional contamination of beddings and cages would occur from feed spillage.
– Dimethyl polysiloxane is a surfactant and has ocular irritating effects. It is expected that due
to this local irritative effect the rats would have scratched their eyes.
– The cornea is not directly vascularised and, therefore, it is not expected to be a target
through systemic exposure.
– Dimethyl polysiloxane has been demonstrated to damage the cornea in humans and rabbits
following intra-ocular treatment only.
Overall, the Panel considered that oral exposure of dimethyl polysiloxane did not result in any
systemic adverse effects in any species and dose tested. From a 26-month toxicity study in rats
(Kawabe et al., 2005), an NOAEL of 1,742 and 2,055 mg dimethyl polysiloxane/kg bw per day for
females and males, respectively, was identified. The Panel noted that the test item was reported not to
be used as a food additive in the EU (Appendix F), nevertheless, the Panel considered it relevant for
the risk assessment of the food additive E 900 because the viscosity complied with the one indicated
in the EU specifications.
The NOAEL identified from the study of Kawabe et al. (2005) is supported by the combined
24 months chronic oral toxicity and carcinogenicity study in rats (WIL-Research-Laboratories-Inc., 2003
(Documentation provided to EFSA No 43)) in which no adverse effects were seen even at the highest
dose tested of 1,000 mg/kg bw per day. The latter study used a low viscosity test item of 10
centistokes, which is outside the viscosity range given in the EU specifications for E 900. Since the low
viscosity implies a low molecular weight distribution, compared to E 900, the test item at 10
centistokes can be considered to be a worse case regarding the extent of the absorption.
The Panel considered that the NOAEL of 1,742 mg/kg body weight per day could be used to derive
an ADI for dimethyl polysiloxane (E 900). Using an uncertainty factor of 100, the Panel derived an ADI
of 17 mg/kg bw per day for dimethyl polysiloxane (E 900).
Dietary exposure to dimethyl polysiloxane (E 900) from its use as a food additive according to
Annex II of Regulation 1333/2008 was calculated according to different exposure scenarios based on
MPLs and reported use levels, as described in Section 3.4. Two food categories that may contain
dimethyl polysiloxane (E 900) according to Annex III of Regulation (EC) No 1333/2008 were also
considered in these exposure scenarios.
The exposure estimates in the regulatory maximum level exposure assessment scenario reached at
the mean 0.23 mg/kg bw per day and 0.51 mg/kg bw per day at the 95th percentile, both for toddlers
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(Table 4). The Panel noted that the estimated long-term exposures based on this scenario are very
likely conservative, as this scenario assumes that all foods and beverages listed under the Annex II of
Regulation (EC) No 1333/2008 contain dimethyl polysiloxane (E 900) as a food additive at the MPL.
Considering that dimethyl polysiloxane (E 900) is authorised in flavoured drinks and changes the
organoleptic properties of these drinks, the Panel selected the brand-loyal refined exposure
assessment scenario as the most relevant scenario for risk characterisation. In this scenario, mean
exposure to dimethyl polysiloxane (E 900) from its use as a food additive ranged from 0.01 mg/kg bw
per day in adults and the elderly to 0.16 mg/kg bw per day in children. The 95th percentile of
exposure to dimethyl polysiloxane (E 900) ranged from 0.02 mg/kg bw per day in the elderly to
0.49 mg/kg bw per day in toddlers.
The Panel considered also the exposure estimates in the refined scenarios as overestimates of the
exposure to dimethyl polysiloxane (E 900) from its use as a food additive according to Annex II of
Regulation 1333/2008. This was mainly due to the assumption that all foods belonging to the food
categories included in these scenarios contained dimethyl polysiloxane (E 900) at the reported use
levels.
The Panel also noted that the refined exposure estimates are based on information provided on the
reported use levels of dimethyl polysiloxane (E 900). If actual practice changes, these refined
estimates may no longer be representative and should be updated.
4. Conclusions
Taking into account the toxicological data available, the Panel established an ADI of 17 mg/kg bw
per day for dimethyl polysiloxane (E 900) based on the NOAEL of 1,742 mg/kg bw per day, the
highest dose tested, and by applying an uncertainty factor of 100. Accordingly, the ADI for dimethyl
polysiloxane (E 900) of 1.5 mg/kg bw per day, established by the SCF in 1990, is withdrawn.
The exposure estimates for the different population groups of all exposure scenarios did not exceed
the ADI of 17 mg/kg bw per day for dimethyl polysiloxane (E 900). The Panel concluded that there is
no safety concern at the reported uses and use levels for dimethyl polysiloxane (E 900).
5. Recommendations
The Panel recommended that the European Commission considers:
• Setting lower limits for toxic elements (arsenic, lead and mercury) in the EU specifications for
dimethyl polysiloxane (E 900) in order to ensure the food additive will not be a significant
source of exposure to those toxic elements in food.
• Including the range of the weight average molecular weight (Mw) and number average
molecular weight (Mn) in the EU specifications for dimethyl polysiloxane (E 900).
• Including a maximum limit for cyclopolysiloxanes in the EU specifications for dimethyl
polysiloxane (E 900).
• Including a maximum limit for copper in the EU specifications for dimethyl polysiloxane (E 900)
• Revising the name of the substance to ‘poly(dimethylsiloxane)’.
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Abbreviations
ADI acceptable daily intake
ANS EFSA Panel on Food Additives and Nutrient Sources added to Food
bw body weight
CAS Chemical Abstracts Service
CONTAM EFSA Panel on Contaminants
ECHA European Chemical Agency
FAF EFSA Panel on Food Additives and Flavourings
FC food category
FCS food categorisation system
FDE Food Drink Europe
GNPD Global New Products Database
GD gestation day
JECFA Joint FAO/WHO Expert Committee on Food Additives
LOD limit of detection
MPL maximum permitted level
Mn number average molecular weight
Mw weight average molecular weight
NOAEL no observed adverse effect level
OECD Organisation for Economic Co-operation and Development
QS quantum satis
SCF Scientific Committee on Food
TemaNord is a publishing series for results of the often research-based work that working groups or
projects under Nordic Council of Ministers have put in motion
TPC total polar compounds content
WHO World Health Organization
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Appendix A – Summary of reported use levels (mg/kg or mg/L as
appropriate) of dimethyl polysiloxane (E 900) provided by industry
Appendix B – Number and percentage of food products labelled with
dimethyl polysiloxane (E 900) out of the total number of food products
present in the Mintel GNPD per food subcategory between 2014 and 2019
Appendix C – Concentration levels of dimethyl polysiloxane (E 900) used in
the exposure assessment scenarios (mg/kg or mL/kg as appropriate)
Appendix D – Summary of total estimated exposure of dimethyl
polysiloxane (E 900) from its use as a food additive for the regulatory
maximum level exposure assessment scenario and the refined exposure
assessment scenarios per population group and survey: mean and 95th
percentile (mg/kg bw per day)
Appendix E – Main food categories contributing to exposure to dimethyl
polysiloxane (E 900) using the regulatory maximum level exposure
assessment scenario and the refined exposure assessment scenarios
(> 5% to the total mean exposure)
Appendixes A–E can be found in the online version of this output (‘Supporting information’ section).
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Appendix F – Characterisation of different dimethyl polysiloxane fluids
used in the toxicological studies
Table F.1: Information on the characterisation of different dimethyl polysiloxane fluids used in the
























Lukasiak et al., 2001 OM-300 na na
Rowe et al., 1948 DC 200 fluids > 99% 50 No
> 99% 350 Yes





EFSA No 39 and 42)





EFSA No 40 and 41)





DC 6370 fluid > 99% 35 No
Data not available 350 No
Data not available 1,000 No
MacDonald et al., 1960 DC 200 fluid > 99% 50 No
> 99% 350 Yes
> 99% 1,000 Yes
> 99% 10,000 No
> 99% 60,000 No
Carson et al., 1966 DC 360 fluid > 99% 50 No
> 99% 350 No
DC Antifoam A 93% 1,500 No
Child et al., 1951 DC Antifoam A 93% 1,500 No
Kennedy et al., 1976 DC 700 vapour
booster pump fluid
Data not available 7 No
Cutler et al., 1974 Silicone antifoam
agent (DC Antifoam A
except that material of





to EFSA No 43)
DC 200 fluid > 99% 10 No
Rowe et al., 1950 DC Antifoam A 93% 1,500 No
Kawabe et al., 2005 KS66(d) 92% 300 mPa s(c) No(e)
Frazer, 1959. (Documentation
provided to EFSA No 29)
DC Antifoam A 93% 1,500 No
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Is it used as
a food
additive?
Hobbs et al., 1972 DC 200 fluid >99% 50 No
>99% 350 Yes







to EFSA No 10)
DC 200 fluid 1 2 No
> 99% 100 No
> 99% 500 No
> 99% 1,000 Yes










‘DC 200 fluid’ (CAS No
107-46-0)













emulsion in tween 80;
emulsions were
performed in water












































No data No data No













74 No data No













79 No data No
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79 No data No













79 No data No








No data 364 No

























7% in Dow Corning
Antifoam A (CAS No
67762-90-7)
7% CAS 67762-90-7 1,500 No
(a): DC Antifoam A is a mixture of 93% polydimethylsiloxane (CAS No 63148-62-9) and 7% silica treated with
polydimethylsiloxane (CAS No 67762-90-7) (Documentation provided to EFSA No 6).
(b): DC Antifoam M is a mixture of 91% polydimethylsiloxane (CAS No 63148-62-9), 6% silica and 3% polydimethylsiloxane
hydroxy-terminated (CAS No 70131-67-8) (Documentation provided to EFSA No 6).
(c): Considering a specific gravity of approximately 0.97, 300 millipascal per second correspond to approximately 310
centistokes.
(d): Test material contains 8% of silica.
(e): KS-66 is not used as a food additive in Europe; Kawabe et al. (2005) study may refer to the use in non-EU regions or to the
use at the time (Documentation provided to EFSA No 6).
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Table G.1: Summary of in vitro genotoxicity data for dimethyl polysiloxane
Test system
Test material
(See Appendix A for
more details)





siloxanes ‘DC 200 fluid’














Reliable with minor limitation. The study was mainly
consistent with OECD TG 471 (1997) except that: No
preliminary toxicity study was performed to select the
maximum concentration to be tested. Only four
concentrations were tested. The Panel considered this
as only a minor deviation from the current version of
the OECD TG 471
Heaxamethyldisiloxane



















Reliable with minor limitation. The study was mainly
consistent with OECD TG 471 (1997) except that: the
experiment was performed as plate incorporation
assay only and that duplicate plates were used in two
to three separate experiments. The Panel considered
this as only a minor deviation from the current version
of the OECD TG 471. However, the relevance of the
study result for the evaluation of ‘dimethyl silicones
and siloxanes’ is low because the fraction of ‘dimethyl
silicones and siloxanes’ in the test material is not
reported. Preliminary toxicity test was performed with
strain TA100 at eight concentrations, between 3 and
10,000 lg/plate. No mutagenicity, bacterial toxicity or




emulsion in tween 80;
emulsions were
performed in water













Reliable with minor limitation. The study was mainly
consistent with OECD TG 471 (1997) except that: the
experiment was performed as plate incorporation
assay only. The Panel considered this as only a minor
deviation from the current version of the OECD TG
471. Study performed in compliance with GLP.
Preliminary toxicity test was performed with TA98, -S9
(0.1, -0.5, 1, 5, 10, 50, 100 ll/plate). No bacterial
toxicity was observed
Appendix G – Summary available genotoxicity studies
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Test system
Test material
(See Appendix A for
more details)





















Reliable with minor limitation. The study was mainly
consistent with OECD TG 471 (1997) except that: No
preliminary toxicity study was performed, and the
experiment was performed as plate incorporation
assay only. However, the relevance of the study result
for the evaluation of ‘dimethyl silicones and siloxanes’
is low because an ethanol extract was tested that































Reliable with minor limitation. The study was mainly
consistent with OECD TG 471 (1997) except that: No
preliminary toxicity study was performed, and the
experiment was performed as plate incorporation
assay only. The Panel considered this as only a minor
deviation from the current version of the OECD TG
471. However, the relevance of the study result for
the evaluation of ‘dimethyl silicones and siloxanes’ is
low because an emulsion was tested that obviously



















Reliable with minor limitation. The study was mainly
consistent with OECD TG 471 (1997) except that: No
preliminary toxicity study was performed, and the
experiment was performed as plate incorporation
assay only. The Panel considered this as only a minor
deviation from the current version of the OECD TG
471
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Test system
Test material
(See Appendix A for
more details)


















Reliable with minor limitation. The procedures used
complied with the OECDTG 471 (1983). Study
performed in compliance with GLP. Preliminary toxicity
test was performed with TA98 (up to 5000 lg per plate).
No bacterial toxicity was observed. The study was mainly
consistent with OECDTG 471 (1997) except that: Only
four Salmonella strains were tested, and the experiment
was performed as plate incorporation assay only. The
Panel considered this as only a minor deviation from the
current version of the OECDTG 471. However, the
relevance of the study result for the evaluation of
‘dimethyl silicones and siloxanes’ is low because the
fraction of ‘dimethyl silicones and siloxanes’ in the test





















Reliable with minor limitation. Study performed in
compliance with GLP. Preliminary toxicity test was
performed with TA100 and WP2 urvA, S9 (up to
5000 lg per plate). No bacterial toxicity was observed.
The study was mainly consistent with OECD TG 471
(1997) except that: Only four Salmonella strains were
tested, and the experiment was performed as
preincubation (for 60 minutes) assay only. The
Panel considered this as only a minor deviation from the
current version of the OECD TG 471. However, the
relevance of the study result for the evaluation of
‘dimethyl silicones and siloxanes’ is low because the test
item contained only 3 wt. % of ‘Dimethyl silicones and



















Reliable with limitation. The study was largely in
compliance with OECD TG 476 (1984) applicable at the
time when the study was performed, but the number
of cells exposed was less than that recommended in
the current version of OECD TG 476 (2016).
www.efsa.europa.eu/efsajournal 45 EFSA Journal 2020;18(5):6107
Re-evaluation of dimethyl polysiloxane (E 900)
Test system
Test material
(See Appendix A for
more details)
Test object Concentration Result Reference Comments
However, the relevance of the study result is low
because the actual concentrations of ‘dimethyl
silicones and siloxanes’ were unclear.(a) Preliminary
cytotoxicity study was performed (S9) between 2
















Reliable with limitation. The study was in compliance
with OECD TG 476 (1984) applicable at the time when
the study was performed, however, the number of
cells exposed was less than that recommended in the
current version of OECD TG 476 (2016). Ethanol was
used as solvent. Preliminary cytotoxicity study was




















Reliable with limitation. The study was largely in
compliance with OECD TG 473 (1983) applicable at
the time when the study was performed, but the
number of cells exposed (200 per concentration) and
the treatment and sampling times (treatment for 6 h
without S9, sampling after two additional hours in the
presence of colcemid; treatment for 2 h with S9,
sampling after 6 additional hours with colcemid
present during the last 2 h) were not in compliance
with the current version of OECD TG 476 (2016).
However, the relevance of the study result is low
because the actual concentrations of ‘dimethyl
silicones and siloxanes’ were unclear(b)
(a): The relevance of the study result is low because the actual concentrations of ‘dimethyl silicones and siloxanes’ were unclear based on what is stated in the study report: ‘Since the material to
be tested was a gel which was not soluble in any solvent compatible with the biological test system, an extraction procedure was used. Ten grams of the test material was extracted with
10 mL of absolute ethanol on a rotary shaker for 24 hours/37°C/150 rpm. The cultures (5 ml) were exposed to a wide range of extract concentrations.’ Thus, different concentrations of the
extract in the cultures were tested for cytotoxicity and mutagenicity. However, the concentration of ‘dimethyl silicones and siloxanes’ in the extract was not reported.
(b): The relevance of the study result is low because the actual concentrations of ‘dimethyl silicones and siloxanes’ were unclear based on what is stated in the study report: ‘Since the material to
be tested was a gel which was not soluble in any solvent compatible with the biological test system, an extraction procedure was used. Ten grams of the test material was extracted with
10 mL of absolute ethanol on a rotary shaker for 24 hours/37°C/150 rpm. The cultures (5 ml) were exposed to a wide range of extract concentrations.’ Thus, different concentrations of the
extract in the cultures were tested for cytotoxicity and mutagenicity. However, the concentration of ‘dimethyl silicones and siloxanes’ in the extract was not reported.
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Reliable with limitation. The study was largely in
compliance with the OECD TG 474 (1983) applicable at
the time when the study was performed but the
number of cells scored (1000 per animal) was less than
that recommended in the current version of OECD TG
474 (2016), i.e. 4000 per animal. Historical control data
not reported. Sampling of peripheral blood cells,
erythroblast was done after 24, 48 and 72 hrs.
The relevance of the study result is low because the




























Reliable with limitation. The study was largely in
compliance with the OECD TG 474 (1983) applicable at
the time when the study was performed but the
number of cells scored (1000 per animal) was less than
that recommended in the current version of OECD TG
474 (2016), i.e. 4000 per animal. Historical control data
not reported. Sampling of peripheral blood was done












5, 10 g/kg Negative Kennedy et al.,
1976
Limited reliability. The study was performed before the
OECD TG 478 was established. Matings were conducted
during six weekly periods following treatment with fresh
untreated females for each mating period. Mutation
rates were evaluated on the basis of both early
resorptions and decreases in viable embryos. One high-
dose male died near the completion of the fifth week of
mating and all males in this group were hypoactive for 3
–5 h following treatment. Data reported are limited.
Number of animals per group is not reported
Cst: Centistoke; MN: Micronucleus test; MTD: Maximum tolerated dose; IP: Intraperitoneal.
(a): The relevance of the study result is low because the actual concentrations of ‘dimethyl silicones and siloxanes’ were unclear based on what is stated in the study report: ‘The test material is
unsoluble in any known acceptable biological diluent. Testing was accomplished therefore, using an extract of the test material. The extract was prepared by continuous rotary shaking of 1 g
test material in Ham’s F-12 tissue culture fluid at 37°C/150 rpm/48 hours followed by sterile filtration (0.22l Milliporetm filter). The cultures (5 mL) were exposed to a wide range of extract
concentrations.’ Thus, different concentrations of the extract in the cultures were tested for cytotoxicity and mutagenicity. However, the concentration of ‘dimethyl silicones and siloxanes’ in
the extract was not reported.
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